Fleisher & Ludwig’s Textbook of Pediatric Emergency Medicine

Fleisher & Ludwig’s Textbook of Pediatric Emergency Medicine

1560 Lei (TVA inclus)
Livrare gratis la comenzi peste 500 RON. Pentru celelalte comenzi livrarea este 20 RON.

Cod produs/ISBN: 9781975121518

Disponibilitate: La comanda in aproximativ 4 saptamani

Editura: LWW

Limba: Engleza

Nr. pagini: 1528

Coperta: Hardcover

Dimensiuni: 21.84 x 5.08 x 28.19 cm

An aparitie: 23 Sept. 2020

Description:

Long considered the gold standard comprehensive reference for diagnosing and managing emergent health issues in children, Fleisher & Ludwig’s Textbook of Pediatric Emergency Medicine is an essential resource for clinicians at all levels of training and experience. The revised eighth edition has been updated from cover to cover, providing practical, evidence-based content to help you meet any clinical challenge in the emergency care of pediatric patients. 

 

Table of Contents:

 

  1. CONTRIBUTING AUTHORS
  2. ACKNOWLEDGMENTS
  3. CONTENTS
  4. SECTION I: Core Principles of Quality and Safety
  5. CHAPTER 1: INTRODUCTION: HIGH-QUALITY EMERGENCY CARE FOR CHILDREN
  6. GOALS OF EMERGENCY CARE
  7. QUALITY AND ITS MEASUREMENT IN PEDIATRIC EMERGENCY MEDICINE
  8. Current Evidence and Practice
  9. High Reliability and Patient Safety
  10. Teamwork and Communication
  11. Cognitive Error
  12. CONCLUSION
  13. CHAPTER 2: INTRODUCTION TO CLINICAL PATHWAYS
  14. BACKGROUND
  15. QUALITY IMPROVEMENT THEORY
  16. APPROACH TO CLINICAL PATHWAY DEVELOPMENT
  17. MEASURING IMPROVEMENT
  18. CHAPTER 3: CLINICAL DECISION SUPPORT
  19. PEOPLE, PROCESS, THEN TECHNOLOGY
  20. CDS OPPORTUNITIES ACROSS A HEALTHCARE ENCOUNTER
  21. Pre-Visit
  22. Assessment and Plan Formulation
  23. Plan Execution
  24. Response to Events
  25. Disposition and Post-Visit
  26. CHAPTER 4: MULTIDISCIPLINARY TEAMWORK
  27. INTRODUCTION
  28. WHY TEAMWORK IS IMPORTANT TO QUALITY AND SAFETY
  29. What Is a Team?
  30. Who Is on a Team?
  31. Team Core Competencies
  32. Facilitating Teamwork
  33. Strategies to Enhance Teamwork
  34. CONCLUSION
  35. CHAPTER 5: HUMANISM IN THE EMERGENCY DEPARTMENT
  36. WHAT IS PROFESSIONALISM?
  37. WHAT IS HUMANISM?
  38. WHAT IS THE RELATIONSHIP OF HUMANISM TO PROFESSIONALISM?
  39. WHY IS BALANCE IMPORTANT? TO THE PATIENT? TO THE DOCTOR?
  40. HOW DO WE MAINTAIN AND PROJECT OUR HUMANISM?
  41. INTRODUCTION AND JOINING
  42. DETAILED SOCIAL HISTORY
  43. PERSONAL INFORMATION
  44. ADDRESSING FEARS
  45. FREQUENT TOUCH POINTS
  46. PARENTAL PRESENCE
  47. SETTING REALISTIC EXPECTATIONS
  48. CHECKING ON COMMUNICATION (FOLLOW-UP)
  49. HUMANISM WITH COLLEAGUES AND STAFF (DEBRIEFINGS–TEAMWORK)
  50. HUMANISM VIA SELF-CARE
  51. SUMMARY
  52. SECTION II: Resuscitation and Stabilization
  53. CHAPTER 6: A GENERAL APPROACH TO TRIAGE
  54. INTRODUCTION
  55. HISTORY OF TRIAGE
  56. CURRENT TRIAGE SYSTEMS
  57. PEDIATRIC TRIAGE CONSIDERATIONS
  58. Triage Process
  59. Pediatric Assessment Triangle
  60. Primary Survey
  61. Secondary Survey
  62. Triage Decision
  63. Triage Documentation
  64. Reassessment
  65. EMTALA
  66. TRENDS IN TRIAGE
  67. Pivot Roles
  68. Split Flow
  69. Immediate Bedding
  70. Provider in Triage
  71. CONCLUSION
  72. CHAPTER 7: A GENERAL APPROACH TO THE ILL OR INJURED CHILD
  73. BACKGROUND AND EPIDEMIOLOGY
  74. PEDIATRIC DIFFERENCES
  75. PRINCIPLES OF CRITICAL ILLNESS AND INJURY IN CHILDREN
  76. Triage
  77. VITAL SIGNS
  78. TEAM COMPOSITION
  79. RAPID ASSESSMENT
  80. PRIMARY SURVEY
  81. Airway
  82. Breathing
  83. Circulation
  84. Disability
  85. Exposure/Environment
  86. IV Access
  87. Fluid Resuscitation
  88. SECONDARY SURVEY
  89. FAMILY PRESENCE
  90. QUALITY AND COMPETENCY
  91. CHAPTER 8: AIRWAY
  92. GOALS OF EMERGENCY THERAPY
  93. Quality and Safety
  94. ALTERNATIVES TO ENDOTRACHEAL INTUBATION
  95. High-Flow Nasal Cannula
  96. Noninvasive Ventilation
  97. APPROACH TO ENDOTRACHEAL INTUBATION
  98. EQUIPMENT
  99. Endotracheal Tubes
  100. Direct Laryngoscopes
  101. Video Laryngoscopes
  102. PREOXYGENATION
  103. PATIENT POSITIONING
  104. MEDICATIONS
  105. Sedatives
  106. Neuromuscular-Blocking Agent (Paralyzing Agent)
  107. Adjunctive Agents
  108. POSTPROCEDURE MANAGEMENT
  109. Maintenance of Sedation Following Tracheal Intubation
  110. RESCUE DEVICES IN PEDIATRIC AIRWAY MANAGEMENT
  111. When to Use
  112. Supraglottic Airways
  113. Other Supraglottic Devices
  114. CHAPTER 9: CARDIOPULMONARY RESUSCITATION
  115. GOALS OF EMERGENCY THERAPY
  116. INCIDENCE
  117. PATIENT CHARACTERISTICS
  118. Age
  119. Etiology
  120. Demographics
  121. TREATMENT OVERVIEW
  122. PROGNOSIS
  123. CLINICAL MANIFESTATIONS
  124. MANAGEMENT
  125. Management Sequence
  126. AIRWAY
  127. Evaluation
  128. MANAGEMENT
  129. Airway Positioning
  130. Artificial Airways
  131. BREATHING
  132. Evaluation
  133. MANAGEMENT
  134. Spontaneous Ventilation
  135. Oxygen Delivery Devices
  136. Assisted Ventilation
  137. Expired Air Techniques
  138. Masks
  139. CIRCULATION
  140. Evaluation
  141. Management
  142. EXTERNAL CARDIAC COMPRESSION
  143. INTRAVENOUS ACCESS
  144. DRUGS OF RESUSCITATION
  145. Estimating Body Weight
  146. Alternative Routes of Medication Administration
  147. FLUID RESUSCITATION
  148. DEFIBRILLATION AND CARDIOVERSION
  149. SPECIFIC RESUSCITATION SCENARIOS
  150. Bradycardia With a Pulse and Poor Perfusion
  151. Pulseless Arrest
  152. Tachydysrhythmias With a Pulse and Poor Perfusion
  153. EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION
  154. NEWLY BORN INFANT RESUSCITATION
  155. EMERGENCY DEPARTMENT READINESS
  156. PATHOPHYSIOLOGY
  157. MANAGEMENT
  158. INITIAL STEPS OF NEWBORN RESUSCITATION
  159. Thermoregulation
  160. Stimulation
  161. Airway
  162. Assessment of Heart Rate
  163. Assessment of Need for Supplemental Oxygen
  164. UMBILICAL CORD MANAGEMENT
  165. INTERVENTIONS
  166. Oxygenation and Ventilation
  167. Supporting Circulation
  168. Other Medications
  169. POSTRESUSCITATION CARE
  170. SPECIAL SITUATIONS
  171. Withholding Resuscitation
  172. Discontinuing Resuscitative Efforts
  173. Induced Therapeutic Hypothermia
  174. Pneumothorax
  175. Congenital Diaphragmatic Hernia
  176. TEAMWORK IN RESUSCITATION FOR ALL PEDIATRIC PATIENTS
  177. DISCONTINUATION OF LIFE SUPPORT IN CHILDREN
  178. CEREBRAL RESUSCITATION
  179. Hypothermia
  180. QUALITY IMPROVEMENT
  181. ETHICAL ISSUES IN PEDIATRIC CARDIOPULMONARY RESUSCITATION
  182. CHAPTER 10: SHOCK
  183. DEFINITION OF SHOCK
  184. GOALS OF EMERGENCY THERAPY
  185. CLINICAL AND PATHOPHYSIOLOGIC CONSIDERATIONS
  186. TYPES OF SHOCK
  187. Hypovolemic Shock
  188. Cardiogenic Shock
  189. Obstructive Shock
  190. Distributive Shock
  191. Neurogenic Shock
  192. Dissociative Shock
  193. CLINICAL CONSIDERATIONS IN SHOCK RECOGNITION
  194. Vital Signs
  195. History and Physical Examination Findings
  196. PRINCIPLES OF SHOCK MANAGEMENT
  197. Vascular Access
  198. Volume Resuscitation
  199. Vasoactive Agents
  200. Electrolyte Abnormalities
  201. Airway Management
  202. Source Control
  203. PROTOCOL-BASED CARE FOR SEPTIC SHOCK
  204. Timely Antimicrobial and Fluid Resuscitation Therapy
  205. Global Considerations
  206. American College of Critical Care Medicine and Surviving Sepsis Campaign Recommendations
  207. Quality Metrics in Pediatric Sepsis
  208. CLINICAL PARAMETERS OF SHOCK REVERSAL
  209. FLUID-REFRACTORY AND CATECHOLAMINE-RESISTANT SHOCK
  210. CONSIDERATIONS FOR INTENSIVE CARE AND TRANSPORT
  211. OUTCOMES
  212. CHAPTER 11: INTERFACILITY TRANSPORT AND STABILIZATION
  213. INTRODUCTION TO PEDIATRIC INTERFACILITY TRANSPORT
  214. TRANSPORT CONSIDERATIONS
  215. MODES OF TRANSPORT
  216. MEDICAL OVERSIGHT
  217. Direct Medical Control
  218. Indirect Medical Control
  219. PEDIATRIC TRANSPORT TEAM STRUCTURE AND LOGISTICS
  220. Education and Training
  221. Quality Improvement
  222. Communication
  223. Patient and Team Safety
  224. Air Transport and Safety
  225. Vehicle Safety
  226. Lights and Siren Use
  227. STABILIZATION FOR TRANSPORT
  228. ALTITUDE PHYSIOLOGY AND THE AIR MEDICAL ENVIRONMENT
  229. MEDICAL–LEGAL ISSUES
  230. SECTION III: Signs and Symptoms
  231. CHAPTER 12: ABDOMINAL DISTENSION
  232. INTRODUCTION
  233. DIFFERENTIAL DIAGNOSIS
  234. EVALUATION AND DECISION
  235. History
  236. Physical Examination
  237. Laboratory
  238. Management
  239. CHAPTER 13: AGITATED CHILD
  240. INTRODUCTION
  241. DIFFERENTIAL DIAGNOSIS
  242. Medical Conditions
  243. Psychiatric Conditions
  244. EVALUATION AND DECISION
  245. General Approach/Initial Stabilization
  246. Medical Conditions
  247. Psychiatric Evaluation
  248. Evaluation of Support Systems
  249. Disposition
  250. CHAPTER 14: APNEA
  251. INTRODUCTION
  252. PATHOPHYSIOLOGY
  253. DIFFERENTIAL DIAGNOSIS
  254. EVALUATION AND DECISION
  255. Initial Stabilization
  256. Has a Significant Apneic Episode Occurred?
  257. Is There an Underlying Cause?
  258. CHAPTER 15: ACUTE ATAXIA
  259. INTRODUCTION
  260. HOW TO DIAGNOSE ATAXIA ON NEUROLOGIC EXAMINATION
  261. DIFFERENTIAL DIAGNOSIS AND ROLE OF IMAGING AND LABORATORY TESTS
  262. MANAGEMENT CONSIDERATIONS
  263. CHAPTER 16: BREAST LESIONS
  264. INTRODUCTION
  265. DIFFERENTIAL DIAGNOSIS
  266. Breast Infections
  267. Benign Cysts and Masses
  268. Malignant Masses
  269. Abnormal Secretions (Nipple Discharge)
  270. Lesions Associated With Pregnancy and Lactation
  271. Miscellaneous Breast Lesions
  272. EVALUATION AND DECISION
  273. History and Physical Examination
  274. Diagnostic Testing
  275. APPROACH
  276. Prepubertal Child
  277. Pubertal/Postpubertal Male
  278. Pubertal/Postpubertal Female
  279. CHAPTER 17: COMA
  280. INTRODUCTION
  281. PATHOPHYSIOLOGY
  282. DIFFERENTIAL DIAGNOSIS
  283. Primary Central Nervous System Disorders
  284. Systemic Abnormalities
  285. EVALUATION AND DECISION
  286. History and Physical Examination
  287. Neurologic Examination and Scoring
  288. Laboratory and Radiologic Studies
  289. Vital Sign Abnormalities
  290. History of Head Trauma
  291. History of Seizures
  292. History of Toxic Ingestions
  293. Increased Intracranial Pressure or Focal Neurologic Defect
  294. Fever
  295. Metabolic Abnormalities
  296. Coma of Unknown Origin
  297. CHAPTER 18: CONSTIPATION
  298. INTRODUCTION
  299. DEFINITION
  300. PHYSIOLOGY
  301. EVALUATION AND DECISION
  302. Acute Constipation
  303. Chronic Constipation
  304. TREATMENT
  305. Approach to the Patient With Severe Chronic Constipation
  306. CHAPTER 19: COUGH
  307. INTRODUCTION
  308. PATHOPHYSIOLOGY
  309. DIFFERENTIAL DIAGNOSIS
  310. EVALUATION AND DECISION
  311. History
  312. Physical Examination
  313. Ancillary Studies
  314. Approach
  315. TREATMENT
  316. CHAPTER 20: CRYING
  317. INTRODUCTION
  318. PATHOPHYSIOLOGY
  319. EVALUATION AND DECISION
  320. ACKNOWLEDGMENTS
  321. CHAPTER 21: CYANOSIS
  322. INTRODUCTION
  323. PATHOPHYSIOLOGY
  324. DIFFERENTIAL DIAGNOSIS
  325. EVALUATION AND DECISION
  326. CHAPTER 22: DEHYDRATION
  327. PATHOPHYSIOLOGY
  328. DIFFERENTIAL DIAGNOSIS
  329. EVALUATION AND DECISION
  330. History
  331. Physical Examination
  332. Laboratory
  333. Diagnostic Approach
  334. Initial Management
  335. Oral Rehydration Therapy
  336. Parenteral Rehydration
  337. CONCLUSION
  338. CHAPTER 23: DIARRHEA
  339. INTRODUCTION
  340. DIFFERENTIAL DIAGNOSIS
  341. EVALUATION AND DECISION
  342. TREATMENT
  343. CHAPTER 24: DIZZINESS AND VERTIGO
  344. INTRODUCTION
  345. PATHOPHYSIOLOGY
  346. DIFFERENTIAL DIAGNOSIS
  347. Infections
  348. Migraine
  349. Benign Paroxysmal Vertigo of Childhood
  350. Ototoxic Drugs
  351. Trauma
  352. Seizures
  353. Motion Sickness
  354. Ménière Disease
  355. Miscellaneous Causes
  356. EVALUATION AND DECISION
  357. Differentiation of True Vertigo and Pseudovertigo
  358. True Vertigo
  359. MANAGEMENT
  360. Pseudovertigo
  361. CHAPTER 25: EDEMA
  362. INTRODUCTION
  363. PATHOPHYSIOLOGY
  364. DIFFERENTIAL DIAGNOSIS
  365. EVALUATION
  366. LOCALIZED EDEMA
  367. GENERALIZED EDEMA
  368. CHAPTER 26: EPISTAXIS
  369. INTRODUCTION
  370. PATHOPHYSIOLOGY
  371. DIFFERENTIAL DIAGNOSIS
  372. Local Causes
  373. Systemic Causes
  374. EVALUATION AND DECISION
  375. CHAPTER 27: EYE: RED EYE
  376. INTRODUCTION
  377. PATHOPHYSIOLOGY
  378. EVALUATION AND DECISION
  379. CHAPTER 28: EYE: STRABISMUS
  380. INTRODUCTION
  381. PATHOPHYSIOLOGY
  382. Nerve Palsies
  383. Muscle Restriction
  384. Strabismus With Intact Eye Muscle Function
  385. EVALUATION AND DECISION
  386. ESOTROPIA EMERGENCIES
  387. EXOTROPIA EMERGENCIES
  388. HYPERTROPIA/HYPOTROPIA EMERGENCIES
  389. CHAPTER 29: EYE: UNEQUAL PUPILS
  390. INTRODUCTION
  391. PATHOPHYSIOLOGY
  392. EVALUATION AND DECISION
  393. ANISOCORIA
  394. MIOSIS
  395. Local Factors
  396. Neurologic Factors
  397. MYDRIASIS
  398. Local Factors
  399. Neurologic Factors
  400. CORECTOPIA AND IRREGULAR PUPILS
  401. UNEQUAL PUPILLARY REACTIVITY
  402. CHAPTER 30: EYE: VISUAL DISTURBANCES
  403. INTRODUCTION
  404. PATHOPHYSIOLOGY
  405. DIFFERENTIAL DIAGNOSIS
  406. EVALUATION AND DECISION
  407. Severe Visual Loss Associated With Trauma
  408. Severe Visual Loss Not Associated With Trauma
  409. Mild Visual Loss With Trauma
  410. Mild Visual Loss Without Trauma
  411. CHAPTER 31: FEVER
  412. INTRODUCTION
  413. PATHOPHYSIOLOGY
  414. EVALUATION AND DECISION
  415. SYMPTOMATIC TREATMENT, DISPOSITION, AND PARENTAL GUIDANCE
  416. DISPOSITION AND DISCHARGE CONSIDERATIONS
  417. CHAPTER 32: FOREIGN BODY: INGESTION AND ASPIRATION
  418. PATHOPHYSIOLOGY
  419. DIFFERENTIAL DIAGNOSIS
  420. Gastrointestinal Foreign Body
  421. Respiratory Foreign Body
  422. EVALUATION AND DECISION
  423. Unknown Location
  424. Gastrointestinal Foreign Body
  425. Respiratory Foreign Body
  426. ACKNOWLEDGMENTS
  427. CHAPTER 33: GASTROINTESTINAL BLEEDING
  428. INTRODUCTION
  429. INITIAL ASSESSMENT
  430. GI Bleed Imitators
  431. Severity of Bleeding
  432. Establishing the Level of Bleeding
  433. UPPER GASTROINTESTINAL BLEEDING
  434. Differential Diagnosis
  435. Neonatal Period (0 to 1 Month)
  436. Infancy (1 Month to 2 Years)
  437. Preschool Period (2 to 5 Years)
  438. School Age Through Adolescence Period
  439. Evaluation and Decision: Upper Gastrointestinal Bleeding
  440. LOWER GASTROINTESTINAL BLEEDING
  441. Differential Diagnosis
  442. Evaluation and Decision: Lower Gastrointestinal Bleeding
  443. Summary
  444. ACKNOWLEDGMENT
  445. CHAPTER 34: HEARING LOSS
  446. PATHOPHYSIOLOGY
  447. DIFFERENTIAL DIAGNOSIS
  448. Conductive Hearing Loss
  449. Congenital Sensorineural Hearing Loss
  450. Acquired Sensorineural Hearing Loss
  451. EVALUATION AND DECISION
  452. CHAPTER 35: HEART MURMURS
  453. DIFFERENTIAL DIAGNOSIS
  454. History
  455. Examination
  456. EVALUATION AND DECISION
  457. Infants With Cardiac Murmur
  458. Cyanotic Infants
  459. Infants Who Are Not Cyanotic
  460. Children Greater Than 1 Year of Age With Murmur
  461. SUMMARY
  462. CHAPTER 36: HEMATURIA
  463. INTRODUCTION
  464. PATHOPHYSIOLOGY
  465. DIFFERENTIAL DIAGNOSIS
  466. Evaluation and Decision
  467. CHAPTER 37: HYPERTENSION
  468. INTRODUCTION
  469. PATHOPHYSIOLOGY/DIFFERENTIAL DIAGNOSIS
  470. EVALUATION AND DECISION
  471. MANAGEMENT
  472. SPECIFIC THERAPY
  473. Intravenous Antihypertensive Medications
  474. Oral Antihypertensive Medications
  475. SUMMARY
  476. CHAPTER 38: IMMOBILE ARM
  477. DIFFERENTIAL DIAGNOSIS
  478. EVALUATION AND DECISION
  479. CHAPTER 39: INGUINAL MASSES
  480. INTRODUCTION
  481. GENERAL APPROACH
  482. DIFFERENTIAL DIAGNOSIS
  483. Lymphadenopathy and Lymphadenitis
  484. Inguinal Hernias
  485. Retractile, Undescended, Ectopic, and Traumatically Dislocated Testes
  486. EVALUATION AND DECISION
  487. CHAPTER 40: INJURY: ANKLE
  488. INTRODUCTION
  489. DIFFERENTIAL DIAGNOSIS
  490. ANKLE FRACTURES
  491. ANKLE SPRAINS
  492. Classification of Ankle Sprains
  493. Injuries Associated With Ankle Sprains
  494. EVALUATION AND DECISION
  495. History
  496. Physical Examination
  497. Radiographic Imaging
  498. Approach
  499. TREATMENT
  500. Fractures
  501. Sprains
  502. Splinting
  503. Rehabilitation
  504. Orthopedic Referral
  505. CHAPTER 41: INJURY: HEAD
  506. PEDIATRIC HEAD TRAUMA
  507. PATHOPHYSIOLOGY
  508. DIFFERENTIAL DIAGNOSIS
  509. Scalp
  510. Skull
  511. Traumatic Brain Injury
  512. Concussion
  513. Posttraumatic Seizure
  514. Cerebral Contusion
  515. Epidural Hematoma
  516. Subdural Hematoma
  517. Intracerebral Hematoma
  518. Subarachnoid Hemorrhage
  519. Diffuse Axonal Injury
  520. Cerebral Edema
  521. Penetrating Injuries
  522. EVALUATION AND DECISION (SEE CHAPTER 113 NEUROTRAUMA)
  523. CLINICAL ASSESSMENT
  524. History
  525. Physical Examination
  526. Radiographic Investigation
  527. Approach
  528. CHAPTER 42: INJURY: KNEE
  529. INTRODUCTION
  530. DIFFERENTIAL DIAGNOSIS
  531. Acute Injuries
  532. Subacute Injuries
  533. EVALUATION AND DECISION
  534. CHAPTER 43: Injury: Shoulder
  535. INTRODUCTION
  536. DIFFERENTIAL DIAGNOSIS
  537. EVALUATION AND DECISION
  538. CHAPTER 44: JAUNDICE: CONJUGATED HYPERBILIRUBINEMIA
  539. INTRODUCTION
  540. NORMAL BILIRUBIN PHYSIOLOGY
  541. DEFINITION
  542. ETIOLOGIES
  543. HISTORY AND PHYSICAL EXAMINATION
  544. EVALUATION
  545. EVALUATION OF THE NEONATE
  546. EVALUATION OF THE OLDER CHILD
  547. LIFE-THREATENING CAUSES NOT TO MISS
  548. Acute Liver Failure
  549. Congenital TORCHS Infections and Sepsis
  550. Biliary Atresia
  551. Metabolic Abnormalities
  552. Obstructive Etiologies: Gallstones, Cysts
  553. Acetaminophen Toxicity
  554. CHAPTER 45: JAUNDICE: UNCONJUGATED HYPERBILIRUBINEMIA
  555. INTRODUCTION
  556. PATHOPHYSIOLOGY
  557. DIFFERENTIAL DIAGNOSIS
  558. Excess Bilirubin Production
  559. Decreased Bilirubin Conjugation
  560. Impaired Bilirubin Excretion
  561. EVALUATION
  562. History
  563. Physical Examination
  564. Additional Studies
  565. MANAGEMENT
  566. Phototherapy
  567. Exchange Transfusion
  568. Hydration
  569. Discharge
  570. APPROACH
  571. Clinical Pathway for Neonates
  572. Beyond the Neonatal Period
  573. CHAPTER 46: LIMP
  574. INTRODUCTION
  575. DIFFERENTIAL DIAGNOSIS
  576. EVALUATION AND DECISION
  577. History
  578. Physical Examination
  579. Laboratory and Imaging
  580. CHAPTER 47: LYMPHADENOPATHY
  581. INTRODUCTION
  582. MECHANISM OF LYMPHADENOPATHY
  583. DIFFERENTIAL DIAGNOSIS
  584. CAUSES OF LYMPHADENOPATHY BY REGION
  585. Cervical
  586. Other Lymphadenopathy of the Head and Neck
  587. Axillary and Epitrochlear
  588. Inguinal
  589. Iliac
  590. GENERALIZED LYMPHADENOPATHY
  591. LIFE-THREATENING LYMPHADENOPATHY
  592. EVALUATION AND DECISION
  593. CHAPTER 48: NECK MASS
  594. INTRODUCTION
  595. INITIAL EVALUATION AND DECISION MAKING
  596. Child With Neck Mass and Respiratory Distress or Systemic Toxicity
  597. Child With Neck Mass and No Distress
  598. DIFFERENTIAL DIAGNOSIS
  599. Congenital Masses
  600. Inflammatory Masses
  601. Neoplasms
  602. GENERAL DIAGNOSTIC APPROACH
  603. DISPOSITION
  604. CHAPTER 49: NECK STIFFNESS
  605. INTRODUCTION
  606. DIFFERENTIAL DIAGNOSIS
  607. Neck Stiffness Associated With Trauma
  608. Neck Stiffness Associated With Infectious/Inflammatory Conditions
  609. Neck Stiffness Associated With Tumors, Vascular Lesions of the Central Nervous System, or Other Space-Occupying Lesions
  610. Congenital Causes of Neck Stiffness
  611. Miscellaneous Causes of Neck Stiffness
  612. EVALUATION AND DECISION
  613. CHAPTER 50: ODOR: UNUSUAL
  614. INTRODUCTION
  615. PATHOPHYSIOLOGY
  616. DIFFERENTIAL DIAGNOSIS
  617. Metabolic Disorders
  618. Toxicologic Considerations
  619. Infectious Diseases
  620. Dermatologic Conditions
  621. Foreign Bodies
  622. Orifice Odors
  623. Systemic Diseases
  624. EVALUATION AND DECISION
  625. CHAPTER 51: OLIGOMENORRHEA
  626. INTRODUCTION
  627. DEFINITIONS
  628. DIFFERENTIAL DIAGNOSIS
  629. EVALUATION AND DECISION
  630. History
  631. Examination
  632. Pregnancy
  633. Evaluation of Nonpregnant Patients
  634. ENDOCRINE ABNORMALITIES
  635. Hyperandrogenism
  636. HYPOTHALAMIC–PITUITARY AXIS DISORDERS
  637. Caloric Insufficiency
  638. Hyperprolactinemia
  639. Ovarian Disorders
  640. Thyroid Disorders
  641. Miscellaneous
  642. APPROACH TO DIAGNOSIS
  643. ACKNOWLEDGMENTS
  644. CHAPTER 52: ORAL LESIONS
  645. INTRODUCTION
  646. PATHOPHYSIOLOGY
  647. DIFFERENTIAL DIAGNOSIS
  648. Congenital Oral Lesions
  649. Infectious Oral Lesions
  650. Tumorous Oral Lesions
  651. Oral Lesions Associated With Systemic Disease
  652. Miscellaneous Oral Lesions
  653. EVALUATION AND DECISION
  654. CHAPTER 53: PAIN: ABDOMEN
  655. INTRODUCTION
  656. PATHOPHYSIOLOGY
  657. DIFFERENTIAL DIAGNOSIS
  658. EVALUATION AND DECISION
  659. Abdominal Pain in the Setting of Trauma
  660. Considerations Among Children With Abdominal Distention or Prior Abdominal Surgery
  661. Abdominal Pain Associated With Peritoneal Signs
  662. Extra-abdominal Conditions Associated With Acute Abdominal Pain
  663. Palpable Mass
  664. Focal Tenderness
  665. Colicky Pain
  666. Fever
  667. Chronic or Recurrent Pattern
  668. Additional Considerations in the Postpubertal Female With Acute Abdominal Pain
  669. SUMMARY
  670. CHAPTER 54: PAIN: BACK
  671. INTRODUCTION
  672. DIFFERENTIAL DIAGNOSIS
  673. EVALUATION AND DECISION
  674. CHAPTER 55: PAIN: CHEST
  675. INTRODUCTION
  676. PATHOPHYSIOLOGY
  677. DIFFERENTIAL DIAGNOSIS
  678. EVALUATION AND DECISION
  679. Child With Thoracic Trauma
  680. Child With No Thoracic Trauma
  681. SUMMARY
  682. CHAPTER 56: PAIN: DYSPHAGIA
  683. INTRODUCTION
  684. PATHOPHYSIOLOGY
  685. DIFFERENTIAL DIAGNOSIS
  686. EVALUATION AND DECISION
  687. CHAPTER 57: PAIN: DYSURIA
  688. INTRODUCTION
  689. EVALUATION AND DECISION
  690. SYMPTOMATIC MANAGEMENT
  691. CHAPTER 58: PAIN: EARACHE
  692. INTRODUCTION
  693. DIFFERENTIAL DIAGNOSIS
  694. OTITIS EXTERNA
  695. ACUTE OTITIS MEDIA
  696. OTORRHEA
  697. COMPLICATIONS OF ACUTE OTITIS MEDIA
  698. TRAUMATIC TM PERFORATION
  699. REFERRED EAR PAIN
  700. CHAPTER 59: PAIN: HEADACHE
  701. INTRODUCTION
  702. PATHOPHYSIOLOGY
  703. DIFFERENTIAL DIAGNOSIS
  704. Vascular
  705. Muscle Contraction
  706. Inflammation
  707. Traction/Compression
  708. Psychogenic
  709. EVALUATION AND DECISION
  710. Clinical Assessment
  711. Laboratory and Radiographic Testing
  712. Treatment and Disposition
  713. CHAPTER 60: PAIN: JOINTS
  714. INTRODUCTION
  715. DIFFERENTIAL DIAGNOSIS
  716. EVALUATION AND DECISION
  717. Trauma
  718. Monoarthritis
  719. Polyarthritis
  720. CHAPTER 61: PAIN: SCROTAL
  721. INTRODUCTION
  722. PATHOPHYSIOLOGY
  723. DIFFERENTIAL DIAGNOSIS
  724. CAUSES OF PAINFUL SCROTAL SWELLING
  725. Torsion of the Testis
  726. Torsion of Testicular Appendage
  727. Epididymitis/Orchitis
  728. Orchitis
  729. Trauma/Hematocele
  730. Incarcerated Inguinal Hernia
  731. Henoch–Schönlein Purpura
  732. Other Causes of a Painful Scrotum
  733. CAUSES OF PAINLESS SCROTAL SWELLING
  734. Hydrocele
  735. Hernia
  736. Varicocele
  737. Spermatocele
  738. Idiopathic Scrotal Edema
  739. Kawasaki Disease
  740. Testis Tumor
  741. Antenatal Torsion Testis (Newborn)
  742. EVALUATION AND DECISION
  743. Initial Approach
  744. History
  745. Physical Examination
  746. Imaging Modalities
  747. CHAPTER 62: PALLOR
  748. INTRODUCTION
  749. DIFFERENTIAL DIAGNOSIS
  750. Decreased Production of Hemoglobin and Red Cells
  751. Hypoplastic and Aplastic Anemias
  752. Disorders of Heme and Globin Production
  753. Systemic Disease
  754. Increased Red Cell Destruction
  755. Membrane Disorders
  756. Enzyme Disorders
  757. Hemoglobinopathies
  758. Immune Hemolytic Anemia
  759. Microangiopathic Anemia
  760. Blood Loss
  761. EVALUATION AND DECISION
  762. SUMMARY
  763. CHAPTER 63: PALPITATIONS
  764. INTRODUCTION
  765. PATHOPHYSIOLOGY
  766. DIFFERENTIAL DIAGNOSIS
  767. Hyperdynamic Cardiac Activity
  768. Sinus Bradycardia
  769. True Cardiac Arrhythmias
  770. EVALUATION AND DECISION
  771. CHAPTER 64: POLYDIPSIA
  772. INTRODUCTION
  773. PATHOPHYSIOLOGY
  774. DIFFERENTIAL DIAGNOSIS
  775. EVALUATION AND DECISION
  776. CHAPTER 65: RASH: ATOPIC/CONTACT DERMATITIS AND PHOTOSENSITIVITY
  777. DERMATITIS
  778. Atopic Dermatitis
  779. Nummular Eczema
  780. Asteatotic Eczema
  781. Dyshidrotic Eczema
  782. Lichen Simplex Chronicus
  783. Contact Dermatitis
  784. Allergic Contact Dermatitis
  785. Irritant Contact Dermatitis
  786. Autoeczematization
  787. PHOTOSENSITIVITY
  788. Polymorphous Light Eruption
  789. Phytophotodermatitis
  790. CHAPTER 66: RASH: BACTERIAL AND FUNGAL INFECTIONS/RASH: MACULOPAPULAR
  791. BACTERIAL INFECTIONS
  792. Pustular Eruptions
  793. Other Pathogens
  794. FUNGAL INFECTIONS
  795. Dermatophytes
  796. CHAPTER 67: RASH: VESICULOBULLOUS
  797. INTRODUCTION
  798. ACQUIRED BLISTERING ERUPTIONS
  799. Infestations
  800. Acropustulosis of Infancy
  801. MASTOCYTOSIS
  802. INHERITED BLISTERING DISEASES
  803. Epidermolysis Bullosa
  804. Incontinentia Pigmenti
  805. AUTOIMMUNE BULLOUS DISORDERS
  806. Linear IgA Disease
  807. Bullous Pemphigoid
  808. Dermatitis Herpetiformis
  809. Systemic Lupus Erythematosus
  810. OTHER BULLOUS ERUPTIONS THAT MAY BE CONFUSED WITH AUTOIMMUNE BLISTERING DISEASES
  811. Friction Blisters
  812. Frostbite
  813. LABORATORY EVALUATION
  814. Gram Stain
  815. Tzanck Smear
  816. Rapid Slide Test for Direct Immunofluorescence
  817. Bacterial or Viral Cultures
  818. Polymerase Chain Reaction
  819. Skin Biopsy
  820. CONCLUSION
  821. CHAPTER 68: RASH: DRUG ERUPTIONS
  822. DRUG ERUPTIONS
  823. URTICARIA
  824. MORBILLIFORM
  825. DRUG HYPERSENSITIVITY REACTION (DHR)/DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS)
  826. PUSTULAR
  827. VESICULOBULLOUS
  828. Fixed Drug
  829. Erythema Multiforme
  830. Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis
  831. CHAPTER 69: RASH: NEONATAL
  832. INTRODUCTION
  833. PUSTULAR ERUPTIONS
  834. Neonatal Acne
  835. Erythema Toxicum Neonatorum
  836. Transient Neonatal Pustular Melanosis
  837. Staphylococcal Pustulosis
  838. Neonatal Candida
  839. Candidal Diaper Dermatitis
  840. Infantile Acropustulosis
  841. VESICULAR ERUPTIONS
  842. Neonatal Herpes Simplex Virus Infections
  843. Incontinentia Pigmenti
  844. PATCHES AND PLAQUES
  845. Annular Rash
  846. Scaly Red Patches and Plaques
  847. Atrophic Patches
  848. Indurated Plaques
  849. Vascular Patches/Plaques and Hamartomas
  850. DARKER AND LIGHTER SKIN LESIONS
  851. CHAPTER 70: RASH: PAPULOSQUAMOUS ERUPTIONS AND VIRAL EXANTHEMS
  852. PAPULOSQUAMOUS ERUPTIONS
  853. Psoriasis
  854. Seborrheic Dermatitis
  855. Pityriasis rosea
  856. Pityriasis rubra pilaris
  857. Pityriasis lichenoides
  858. Lichen nitidus
  859. Lichen planus
  860. Lichen striatus
  861. VIRAL SYNDROMES
  862. Kaposi Varicelliform Eruption
  863. Papular-Purpuric Gloves-and-Socks Eruption
  864. Unilateral Laterothoracic Exanthem
  865. GIANOTTI–CROSTI SYNDROME (PAPULAR ACRODERMATITIS OF CHILDHOOD, PAPULOVESICULAR ACROLOCATED SYNDROME)
  866. CONCLUSION
  867. CHAPTER 71: RESPIRATORY DISTRESS
  868. INTRODUCTION
  869. PATHOPHYSIOLOGY
  870. DIFFERENTIAL DIAGNOSIS
  871. Respiratory System
  872. Nervous System
  873. Chest Wall/Thoracic Cavity
  874. Cardiovascular
  875. Gastrointestinal
  876. Metabolic and Endocrine Disturbances
  877. Hematologic
  878. EVALUATION AND DECISION
  879. Triage and Stabilization
  880. History
  881. Physical Examination
  882. Approach
  883. Treatment
  884. SUMMARY
  885. CHAPTER 72: SEIZURES
  886. BACKGROUND
  887. PATHOPHYSIOLOGY
  888. ETIOLOGY
  889. DIFFERENTIAL DIAGNOSIS
  890. INITIAL STABILIZATION
  891. EVALUATION AND DECISION
  892. History
  893. Planning for an Active Seizure
  894. Physical Examination
  895. DIAGNOSTIC APPROACH
  896. EMERGENCY TREATMENT OF AN ACTIVE SEIZURE
  897. Prevention and Preparation
  898. Medical Management of an Active Seizure Beyond the Neonatal Period
  899. SPECIAL CONSIDERATIONS
  900. Febrile Seizures
  901. CHAPTER 73: SEPTIC-APPEARING INFANT
  902. INTRODUCTION
  903. DIFFERENTIAL DIAGNOSIS
  904. Sepsis
  905. Other Infectious Diseases
  906. Cardiac Diseases (See Chapter 86 Cardiac Emergencies)
  907. Endocrine Disorders (See Chapter 89 Endocrine Emergencies)
  908. Metabolic Disorders
  909. Renal Disorders (See Chapter 100 Renal and Electrolyte Emergencies)
  910. Hematologic Disorders
  911. Gastrointestinal Disorders (See Chapter 91 Gastrointestinal Emergencies)
  912. Neurologic Diseases
  913. Child Abuse
  914. EVALUATION AND DECISION
  915. CHAPTER 74: SORE THROAT
  916. INTRODUCTION
  917. DIFFERENTIAL DIAGNOSIS
  918. Infectious Pharyngitis
  919. Irritative Pharyngitis/Foreign Body
  920. Herpetic Stomatitis
  921. Peritonsillar Abscess
  922. Retropharyngeal and Lateral Pharyngeal Abscesses
  923. Epiglottitis
  924. Kawasaki Disease
  925. Stevens–Johnson Syndrome
  926. Chemical Exposure
  927. Referred Pain
  928. Psychogenic Pharyngitis
  929. Pharyngitis in the Immunosuppressed Host
  930. EVALUATION AND DECISION
  931. CHAPTER 75: STRIDOR
  932. INTRODUCTION
  933. PATHOPHYSIOLOGY
  934. DIFFERENTIAL DIAGNOSIS
  935. Stridor With Acute Onset in the Febrile Child
  936. Stridor With Acute Onset in the Afebrile Child
  937. Chronic Stridor
  938. EVALUATION AND DECISION
  939. Febrile Child
  940. Afebrile Child
  941. CHAPTER 76: SYNCOPE
  942. INTRODUCTION
  943. AUTONOMIC (VASOVAGAL OR NEUROCARDIOGENIC) SYNCOPE
  944. CARDIAC SYNCOPE
  945. Long QT Syndrome (LQTS)
  946. Brugada Syndrome
  947. Structural Heart Disease
  948. Other Arrhythmias
  949. OTHER CONDITIONS AND THOSE THAT MIMIC SYNCOPE
  950. Hypoglycemia
  951. Epilepsy
  952. Narcolepsy
  953. Vertebrobasilar Migraine or Transient Ischemic Attacks
  954. Psychogenic Causes of Syncope
  955. Orthostatic Intolerance
  956. Dysautonomia
  957. Drugs and Toxins
  958. CLINICAL EVALUATION
  959. Electrocardiogram (ECG)
  960. Other Tests
  961. TREATMENT
  962. SUMMARY POINTS
  963. CHAPTER 77: TACHYCARDIA
  964. INTRODUCTION
  965. PATHOPHYSIOLOGY
  966. DIFFERENTIAL DIAGNOSIS
  967. Sinus Tachycardia
  968. Tachyarrhythmias
  969. EVALUATION AND DECISION
  970. CHAPTER 78: URINARY FREQUENCY
  971. INTRODUCTION
  972. PATHOPHYSIOLOGY
  973. DIFFERENTIAL DIAGNOSIS
  974. Renal and Urinary System
  975. Extraurinary System
  976. EVALUATION AND DECISION
  977. CHAPTER 79: VAGINAL BLEEDING
  978. INTRODUCTION
  979. VAGINAL BLEEDING IN THE PREPUBERTAL PATIENT
  980. Evaluation and Decision
  981. Vulvar Bleeding
  982. Vaginal Bleeding
  983. Urethral Bleeding
  984. BLEEDING IN THE NONPREGNANT ADOLESCENT PATIENT
  985. Normal Menstrual Cycle
  986. Evaluation and Decision in the Nonpregnant Adolescent
  987. Causes of Uterine Bleeding in the Adolescent Patient
  988. Treatment Options
  989. BLEEDING IN THE PREGNANT PATIENT
  990. Bleeding During Early Pregnancy
  991. Bleeding During an Ectopic Pregnancy
  992. Bleeding During Late Pregnancy
  993. Bleeding With Shock
  994. CHAPTER 80: VAGINAL DISCHARGE
  995. INTRODUCTION
  996. EVALUATION OF VAGINAL DISCHARGE IN THE PREPUBERTAL CHILD
  997. Differential Diagnosis
  998. Examination
  999. Diagnostic Testing and Treatment
  1000. EVALUATION OF VAGINAL DISCHARGE IN THE ADOLESCENT
  1001. Differential Diagnosis
  1002. Examination
  1003. Diagnostic Testing and Treatment
  1004. CHAPTER 81: VOMITING
  1005. INTRODUCTION
  1006. EVALUATION AND DECISION
  1007. General Approach
  1008. History
  1009. Physical Examination
  1010. APPROACH TO CHILDREN BY AGE GROUPS
  1011. Neonates
  1012. Older Infants
  1013. Older Child
  1014. CHAPTER 82: WEAKNESS
  1015. INTRODUCTION
  1016. PATHOPHYSIOLOGY
  1017. DIFFERENTIAL DIAGNOSIS
  1018. EVALUATION AND DECISION
  1019. CHAPTER 83: WEIGHT LOSS
  1020. INTRODUCTION
  1021. PATHOPHYSIOLOGY
  1022. EVALUATION AND DECISION MAKING
  1023. General Approach
  1024. DIFFERENTIAL DIAGNOSIS BY AGE
  1025. Infants
  1026. Toddlers Through Preadolescents
  1027. Adolescents
  1028. Disposition
  1029. SUMMARY
  1030. CHAPTER 84: WHEEZING
  1031. INTRODUCTION
  1032. PATHOPHYSIOLOGY
  1033. DIFFERENTIAL DIAGNOSIS
  1034. Common Conditions
  1035. Less Common Conditions
  1036. Rare Conditions
  1037. EVALUATION
  1038. History
  1039. Physical Examination
  1040. DIAGNOSTIC TESTS
  1041. APPROACH
  1042. CHILDREN YOUNGER THAN 1 YEAR OLD
  1043. CHILD 1 YEAR OR OLDER
  1044. SECTION IV: Medical Emergencies
  1045. CHAPTER 85: ALLERGIC EMERGENCIES
  1046. GOALS OF EMERGENCY THERAPY
  1047. ANAPHYLAXIS
  1048. Goals of Treatment
  1049. Current Evidence
  1050. Clinical Considerations
  1051. HEREDITARY ANGIOEDEMA
  1052. Current Evidence
  1053. Goals of Treatment
  1054. Clinical Considerations
  1055. SERUM SICKNESS
  1056. Current Evidence
  1057. Goals of Treatment
  1058. Clinical Considerations
  1059. ALLERGIC RHINITIS AND CONJUNCTIVITIS
  1060. Current Evidence
  1061. Goals of Treatment
  1062. Clinical Considerations
  1063. CHAPTER 86: CARDIAC EMERGENCIES
  1064. GOALS OF EMERGENCY THERAPY
  1065. CONGENITAL HEART DISEASE
  1066. Goals of Treatment
  1067. Current Evidence
  1068. Clinical Considerations
  1069. Ductal Dependent Lesions
  1070. Ductal Dependent Pulmonary Blood Flow
  1071. Ductal Dependent Systemic Blood Flow
  1072. Shunt Lesions
  1073. Adults With Congenital Heart Disease
  1074. ARRHYTHMIC EMERGENCIES
  1075. Goal of Treatment
  1076. Current Evidence
  1077. Clinical Considerations
  1078. SUDDEN CARDIAC DEATH
  1079. ACUTE HEART FAILURE SYNDROMES
  1080. Current Evidence
  1081. Goal of Treatment
  1082. Clinical Considerations
  1083. ACQUIRED HEART DISEASE
  1084. Goals of Treatment
  1085. CARDIOMYOPATHIES
  1086. MYOCARDITIS
  1087. PERICARDITIS
  1088. CARDIAC TAMPONADE
  1089. BACTERIAL ENDOCARDITIS
  1090. ACUTE RHEUMATIC FEVER
  1091. KAWASAKI DISEASE
  1092. MYOCARDIAL INFARCTION
  1093. CARDIAC TRAUMA
  1094. Goals of Treatment
  1095. Current Evidence
  1096. Clinical Considerations
  1097. Blunt
  1098. Penetrating
  1099. Electrical
  1100. EVALUATION OF THE PATIENT WITH A CARDIAC DEVICE
  1101. Goals of Treatment
  1102. Current Evidence
  1103. Clinical Considerations
  1104. CHAPTER 87: CHILD ABUSE/ASSAULT
  1105. GOALS OF EMERGENCY CARE
  1106. INJURIES FROM PHYSICAL ABUSE: GENERAL
  1107. Clinical Considerations
  1108. CUTANEOUS MANIFESTATIONS OF ABUSE: BRUISES, BURNS, AND BITES
  1109. Goals of Treatment
  1110. Current Evidence
  1111. Clinical Considerations
  1112. OROPHARYNGEAL INJURIES FROM ABUSE
  1113. Goals of Treatment
  1114. Current Evidence
  1115. Clinical Considerations
  1116. ABUSIVE FRACTURES
  1117. Goals of Treatment
  1118. Current Evidence
  1119. Clinical Considerations
  1120. ABUSIVE HEAD TRAUMA
  1121. Goals of Treatment
  1122. Current Evidence
  1123. Clinical Considerations
  1124. ABUSIVE ABDOMINAL TRAUMA
  1125. Goals of Treatment
  1126. Current Evidence
  1127. Clinical Considerations
  1128. CHAPTER 88: DERMATOLOGIC URGENCIES AND EMERGENCIES
  1129. GOALS OF EMERGENCY CARE
  1130. PAPULES
  1131. Papules With a Characteristic Appearance
  1132. Milia
  1133. Molluscum Contagiosum
  1134. Warts
  1135. Xanthomas
  1136. Insect Bites
  1137. Tick Bites
  1138. Spider Bites
  1139. Scabies Infestation
  1140. Louse Infestation
  1141. Vascular Papules and Nodules
  1142. Yellow, Tan, or Brown Papules
  1143. Skin-Colored Papules
  1144. PLAQUES
  1145. Annular Plaques
  1146. NODULES
  1147. Panniculitis
  1148. Generalized Macules and Papules/Morbilliform Eruptions
  1149. EVALUATION AND DECISION
  1150. DIFFERENTIAL DIAGNOSIS
  1151. Presence of Fever
  1152. Potentially Life-threatening Illnesses
  1153. Causes of Other Widespread Rashes Associated With Fever
  1154. Nonspecific Viral Exanthems
  1155. Generalized Eruptions Without Fever
  1156. Vesicles/Bullae
  1157. Localized Eruptions Without Fever
  1158. Chronic Eruptions Without Fever
  1159. PAPULOSQUAMOUS ERUPTIONS/SCALY RED PATCHES AND PLAQUES
  1160. Conditions That Lack Pruritus
  1161. Pruritic Papulosquamous Disorders
  1162. VASCULAR LESIONS
  1163. Pyogenic Granulomas
  1164. Hemangioma
  1165. URTICARIA/WHEALS
  1166. Clinical Manifestations
  1167. Management
  1168. CHAPTER 89: ENDOCRINE EMERGENCIES
  1169. DIABETIC KETOACIDOSIS
  1170. Goals of Treatment
  1171. Current Evidence
  1172. Clinical Considerations
  1173. MILD KETOACIDOSIS/HYPERGLYCEMIA
  1174. Goals of Treatment
  1175. Current Evidence
  1176. Clinical Considerations
  1177. HYPOGLYCEMIA
  1178. Goal of Treatment
  1179. Current Evidence
  1180. Clinical Considerations
  1181. HYPOPITUITARISM
  1182. Goal of Treatment
  1183. Current Evidence
  1184. Clinical Considerations
  1185. ACUTE ADRENAL INSUFFICIENCY
  1186. Goal of Treatment
  1187. Current Evidence
  1188. Clinical Considerations
  1189. CONGENITAL ADRENAL HYPERPLASIA
  1190. Goal of Treatment
  1191. Current Evidence
  1192. Clinical Considerations
  1193. PHEOCHROMOCYTOMA
  1194. Goal of Treatment
  1195. Current Evidence
  1196. Clinical Considerations
  1197. DIABETES INSIPIDUS
  1198. Goal of Treatment
  1199. Current Evidence
  1200. Clinical Considerations
  1201. SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION
  1202. Goals of Treatment
  1203. Current Evidence
  1204. Clinical Considerations
  1205. HYPERPARATHYROIDISM
  1206. Goal of Treatment
  1207. Current Evidence
  1208. Clinical Considerations
  1209. HYPOPARATHYROIDISM
  1210. Goal of Treatment
  1211. Current Evidence
  1212. Clinical Considerations
  1213. RICKETS
  1214. Goals of Treatment
  1215. Current Evidence
  1216. Clinical Considerations
  1217. THYROID STORM
  1218. Goals of Treatment
  1219. Current Evidence
  1220. Clinical Considerations
  1221. NEONATAL THYROTOXICOSIS
  1222. Goals of Treatment
  1223. Current Evidence
  1224. Clinical Considerations
  1225. CONGENITAL HYPOTHYROIDISM
  1226. Goal of Treatment
  1227. Current Evidence
  1228. Clinical Considerations
  1229. CHAPTER 90: ENVIRONMENTAL EMERGENCIES, RADIOLOGICAL EMERGENCIES, BITES AND STINGS
  1230. DROWNING
  1231. Goals of Treatment
  1232. Current Evidence
  1233. Clinical Recognition
  1234. Triage Considerations
  1235. Initial Assessment
  1236. Management and Diagnostic Testing
  1237. Indications for Discharge or Admission
  1238. SMOKE INHALATION
  1239. Goals of Treatment
  1240. Current Evidence
  1241. Clinical Recognition
  1242. Triage Considerations
  1243. Clinical Assessment
  1244. Management and Diagnostic Studies
  1245. Indications for Discharge or Admission
  1246. CARBON MONOXIDE POISONING
  1247. Goals of Treatment
  1248. Current Evidence
  1249. Clinical Recognition
  1250. Triage Considerations
  1251. Clinical Assessment
  1252. Management and Diagnostic Studies
  1253. Indications for Discharge or Admission
  1254. ENVIRONMENTAL AND EXERTIONAL HEAT ILLNESS
  1255. Goals of Treatment
  1256. Current Evidence
  1257. Clinical Recognition
  1258. Management and Diagnostic Studies
  1259. Indications for Admission and Discharge
  1260. ACCIDENTAL HYPOTHERMIA
  1261. Goals of Treatment
  1262. Current Evidence
  1263. Clinical Recognition
  1264. Triage Considerations
  1265. Initial Assessment
  1266. Management and Diagnostic Studies
  1267. Indications for Admission and Discharge
  1268. FROSTBITE INJURY
  1269. Clinical Recognition
  1270. HIGH-ALTITUDE ILLNESS
  1271. Goals of Treatment
  1272. Current Evidence
  1273. Clinical Recognition
  1274. Triage and Initial Assessment
  1275. Management and Diagnostic Studies
  1276. Prevention
  1277. ELECTRICAL INJURIES
  1278. Goals of Treatment
  1279. Current Evidence
  1280. Clinical Recognition
  1281. Management and Diagnostic Studies
  1282. Indications for Discharge and Admission
  1283. RADIATION INJURIES
  1284. Goals of Treatment
  1285. Current Evidence
  1286. Triage Considerations
  1287. Management and Diagnostic Studies
  1288. BITES AND STINGS
  1289. Goals of Treatment
  1290. MARINE INVERTEBRATES
  1291. Phylum Coelenterata (Cnidaria)
  1292. Phylum Echinodermata
  1293. MARINE VERTEBRATES
  1294. Stingrays
  1295. Sharks
  1296. Scorpaenidae
  1297. Catfish
  1298. TERRESTRIAL INVERTEBRATES
  1299. Phylum Arthropoda
  1300. TERRESTRIAL VERTEBRATES
  1301. Venomous Reptiles
  1302. MAMMALIAN BITES
  1303. Goals of Treatment
  1304. Current Evidence
  1305. Clinical Considerations
  1306. Clinical Assessment
  1307. Management
  1308. CHAPTER 91: GASTROINTESTINAL EMERGENCIES
  1309. GOALS OF EMERGENCY CARE
  1310. GASTROINTESTINAL BLEEDING
  1311. Goals of Treatment
  1312. UPPER GASTROINTESTINAL BLEEDING
  1313. Esophageal Varices
  1314. PEPTIC ULCER DISEASE
  1315. Goals of Treatment
  1316. Clinical Evidence
  1317. Clinical Considerations
  1318. MALLORY–WEISS TEARS/PROLAPSE GASTROPATHY
  1319. LOWER GI BLEEDING
  1320. Inflammatory Bowel Disease
  1321. DIETARY PROTEIN GASTROINTESTINAL DISORDERS
  1322. Goals of Treatment
  1323. Current Evidence
  1324. Clinical Considerations
  1325. ADDITIONAL CAUSES OF GASTROINTESTINAL BLEEDING
  1326. Hemolytic Uremic Syndrome
  1327. Henoch–Schönlein Purpura
  1328. Gastrointestinal Vascular Malformations
  1329. Foreign Bodies
  1330. PANCREATITIS
  1331. Goals of Treatment
  1332. Current Evidence
  1333. Clinical Considerations
  1334. BILIARY TRACT DISEASE
  1335. Biliary Atresia
  1336. CHOLELITHIASIS/CHOLECYSTITIS
  1337. ALAGILLE SYNDROME
  1338. LIVER DISEASE
  1339. Acute Liver Failure
  1340. PORTAL HYPERTENSION
  1341. ACUTE VIRAL HEPATITIS
  1342. Goals of Emergency Therapy
  1343. Current Evidence
  1344. Clinical Considerations
  1345. POSTEXPOSURE PROPHYLAXIS
  1346. Hepatitis A
  1347. Hepatitis B
  1348. MISCELLANEOUS ABDOMINAL EMERGENCIES
  1349. Gastroesophageal Reflux Disease
  1350. Celiac Disease
  1351. Mesenteric Lymphadenitis
  1352. Reye Syndrome
  1353. CHAPTER 92: GYNECOLOGY EMERGENCIES
  1354. GOALS OF EMERGENCY CARE
  1355. PREGNANCY
  1356. Goals of Treatment
  1357. Current Evidence
  1358. Clinical Considerations
  1359. EMERGENCY CONTRACEPTION
  1360. VAGINITIS
  1361. Goals of Treatment
  1362. Current Evidence
  1363. TRICHOMONAL VAGINITIS
  1364. Clinical Considerations
  1365. SHIGELLA VAGINITIS
  1366. Clinical Considerations
  1367. STREPTOCOCCAL VAGINITIS
  1368. Clinical Considerations
  1369. CANDIDAL VAGINITIS
  1370. Clinical Considerations
  1371. BACTERIAL VAGINOSIS
  1372. Clinical Considerations
  1373. NONSPECIFIC VAGINITIS
  1374. Clinical Considerations
  1375. CERVICITIS
  1376. Goals of Treatment
  1377. Current Evidence
  1378. Clinical Considerations
  1379. PELVIC INFLAMMATORY DISEASE
  1380. Goals of Treatment
  1381. Current Evidence
  1382. Clinical Considerations
  1383. ADNEXAL TORSION
  1384. Goals of Treatment
  1385. Current Evidence
  1386. Clinical Considerations
  1387. DISEASES THAT PRODUCE EXTERNAL GENITOURINARY LESIONS
  1388. Herpes Simplex Virus Infection
  1389. HPV
  1390. DISORDERS OF MENSTRUATION
  1391. Dysmenorrhea
  1392. ABNORMAL UTERINE BLEEDING
  1393. Goals of Treatment
  1394. Background
  1395. Clinical Manifestations
  1396. Management
  1397. LICHEN SCLEROSIS
  1398. CONGENITAL VAGINAL OBSTRUCTION
  1399. LABIAL ADHESIONS
  1400. URETHRAL PROLAPSE
  1401. Clinical Manifestations
  1402. Management
  1403. Contraceptive Devices
  1404. INTRAUTERINE DEVICES
  1405. Clinical Manifestations
  1406. Management
  1407. SUBDERMAL HORMONAL IMPLANT
  1408. Clinical Manifestations
  1409. Management
  1410. CHAPTER 93: HEMATOLOGIC EMERGENCIES
  1411. GOALS OF EMERGENCY THERAPY
  1412. ANEMIA
  1413. Goals of Treatment
  1414. Current Evidence
  1415. BLOOD LOSS
  1416. Clinical Considerations
  1417. HEMOLYTIC ANEMIA
  1418. Current Evidence
  1419. Goals of Treatment
  1420. Clinical Considerations
  1421. METHEMOGLOBINEMIA
  1422. Goals of Treatment
  1423. Clinical Considerations
  1424. INEFFECTIVE OR DECREASED RED BLOOD CELL PRODUCTION
  1425. Current Evidence
  1426. Clinical Considerations
  1427. SICKLE CELL DISEASE
  1428. Goals of Treatment
  1429. Clinical Considerations
  1430. Vasoocclusive Pain Episodes
  1431. Visceral Pain Crises and Hepatobiliary Disease
  1432. Priapism
  1433. Infection/Sepsis
  1434. Acute Chest Syndrome
  1435. Stroke
  1436. Anemia
  1437. Splenic Sequestration
  1438. Papillary Necrosis
  1439. Avascular Necrosis
  1440. Transfusions
  1441. NEUTROPENIA
  1442. Goals of Treatment
  1443. Current Evidence
  1444. Clinical Considerations
  1445. DISORDERS OF NEUTROPHIL FUNCTION
  1446. PLATELET DISORDERS
  1447. Goals of Treatment
  1448. IMMUNE THROMBOCYTOPENIA
  1449. Current Evidence
  1450. Clinical Considerations
  1451. OTHER DISORDERS ASSOCIATED WITH THROMBOCYTOPENIA
  1452. Neonatal Thrombocytopenia
  1453. Heparin-Induced Thrombocytopenia
  1454. Nonimmune Thrombocytopenia
  1455. THROMBOCYTOSIS
  1456. Goals of Treatment
  1457. Clinical Considerations
  1458. DISORDERS OF HEMOSTASIS
  1459. Goals of Treatment
  1460. Current Evidence
  1461. Clinical Considerations
  1462. Diagnostic Testing
  1463. Management
  1464. Clinical Indications for Discharge or Admission
  1465. HEMOPHILIA
  1466. Goals of Treatment
  1467. Current Evidence
  1468. Clinical Considerations
  1469. VON Willebrand Disease
  1470. Current Evidence
  1471. Clinical Considerations
  1472. HYPERCOAGULABILITY
  1473. Goals of Treatment
  1474. Current Evidence
  1475. Clinical Considerations
  1476. TRANSFUSION REACTIONS
  1477. Clinical Recognition
  1478. Management
  1479. CHAPTER 94: INFECTIOUS DISEASE EMERGENCIES
  1480. GOALS OF EMERGENCY CARE
  1481. BACTEREMIA AND SEPSIS
  1482. Current Evidence
  1483. Goals of Treatment
  1484. Clinical Considerations
  1485. OTHER SYSTEMIC INFECTIOUS EMERGENCIES
  1486. Goals of Treatment
  1487. Toxic Shock Syndrome
  1488. Rickettsial Diseases
  1489. Babesiosis
  1490. CNS INFECTIOUS EMERGENCIES
  1491. Meningitis, Bacterial
  1492. Herpes Simplex Virus, Neonatal
  1493. Meningitis, Aseptic
  1494. Encephalitis and Meningoencephalitis
  1495. Other CNS Infections
  1496. Acute Flaccid Paralysis
  1497. NECK INFECTIOUS EMERGENCIES
  1498. Cervical Lymphadenitis
  1499. Other Neck Infectious Emergencies
  1500. RESPIRATORY TRACT INFECTIOUS EMERGENCIES
  1501. Upper Respiratory Tract Infectious Emergencies
  1502. LOWER RESPIRATORY TRACT INFECTIOUS EMERGENCIES
  1503. Pneumonia
  1504. Other Respiratory Tract Infectious Emergencies
  1505. CARDIAC INFECTIOUS EMERGENCIES
  1506. Kawasaki Disease
  1507. Other Cardiac Infectious Emergencies
  1508. GASTROINTESTINAL INFECTIOUS EMERGENCIES
  1509. Gastroenteritis—Viral
  1510. Gastroenteritis—Bacterial
  1511. Hemolytic Uremic Syndrome
  1512. Nontyphi Salmonella
  1513. Shigella
  1514. Antibiotic-Associated Colitis
  1515. Intra-Abdominal Abscesses
  1516. GENITOURINARY INFECTIOUS EMERGENCIES
  1517. Urinary Tract Infections
  1518. SKIN AND SOFT TISSUE INFECTIOUS EMERGENCIES
  1519. Impetigo
  1520. Cellulitis
  1521. Mastitis, Neonatal
  1522. Omphalitis
  1523. Septic Arthritis
  1524. Lyme Disease Arthritis
  1525. Osteomyelitis
  1526. INFECTIONS IN RETURNED TRAVELERS
  1527. Introduction
  1528. Malaria
  1529. Tuberculosis
  1530. Typhoid
  1531. Dengue
  1532. Chikungunya
  1533. Zika
  1534. Diarrheal Diseases
  1535. SYSTEMIC INFECTIONS IN THE RETURNED TRAVELER
  1536. Yellow Fever
  1537. Leptospirosis
  1538. Tick-borne Diseases
  1539. Plague
  1540. CENTRAL/PERIPHERAL NERVOUS SYSTEM
  1541. Neurocysticercosis
  1542. Rabies
  1543. African Trypanosomiasis
  1544. CARDIAC INFECTIONS
  1545. Chagas Disease
  1546. RESPIRATORY TRACT INFECTIONS
  1547. Coronaviruses (SARS, MERS)
  1548. Diphtheria
  1549. Hantavirus
  1550. Lymphadenopathy
  1551. Measles
  1552. Mumps
  1553. Brucella
  1554. GASTROINTESTINAL/GENITOURINARY
  1555. Amebiasis
  1556. Giardia
  1557. Cryptosporidium
  1558. Gram-negative Enterics: Vibrio, E. coli, Campylobacter, Shigella
  1559. Schistosomiasis
  1560. Soil Helminthic Infections
  1561. SKIN/SOFT TISSUE INFECTIONS
  1562. Leishmaniasis
  1563. Cutaneous Larva Migrans
  1564. Filariasis
  1565. SEXUALLY TRANSMITTED INFECTIONS
  1566. Chlamydia, Neonatal
  1567. Gonorrhea, Neonatal
  1568. Gonorrhea, Disseminated
  1569. Herpes Simplex Virus, Nonneonatal
  1570. Human Immunodeficiency Virus
  1571. Syphilis, Congenital
  1572. Syphilis, Acquired
  1573. CHAPTER 95: METABOLIC EMERGENCIES
  1574. GOALS OF EMERGENCY THERAPY
  1575. UNKNOWN SUSPECTED IEM
  1576. Goals of Treatment
  1577. Current Understanding
  1578. Clinical Considerations
  1579. KNOWN IEM
  1580. Goals of Treatment
  1581. Current Understanding
  1582. Clinical Considerations
  1583. AMINO ACID DISORDERS
  1584. Goals of Treatment
  1585. Current Understanding
  1586. Clinical Considerations
  1587. ORGANIC ACIDEMIAS
  1588. Goals of Treatment
  1589. Current Understanding
  1590. Clinical Considerations
  1591. UREA CYCLE DEFECTS
  1592. Goals of Treatment
  1593. Current Understanding
  1594. Clinical Considerations
  1595. FATTY ACID OXIDATION DEFECTS
  1596. Goals of Treatment
  1597. Clinical Understanding
  1598. Current Considerations
  1599. CARBOHYDRATE DISORDERS
  1600. Disorders of Carbohydrate Intolerance
  1601. Goals of Treatment
  1602. Clinical Considerations
  1603. Disorders of Carbohydrate Production or Utilization
  1604. NEONATE WITH POSITIVE NEWBORN SCREEN
  1605. Goals of Treatment
  1606. Current Understanding
  1607. Clinical Considerations
  1608. SUMMARY
  1609. CHAPTER 96: NEONATAL EMERGENCIES
  1610. INTRODUCTION AND INITIAL ASSESSMENT
  1611. Goals of Emergency Care
  1612. Current Evidence
  1613. Goals of Treatment
  1614. Clinical Considerations
  1615. COLOR CHANGES AND DERMATOLOGIC FINDINGS
  1616. Goals of Emergency Care
  1617. Color Changes
  1618. Dermatologic Findings
  1619. Benign Rashes
  1620. Significant Neonatal Rashes (See Chapter 69 Rash: Neonatal)
  1621. NEONATAL HEAD AND NECK EMERGENCIES
  1622. Disorders of Head Size, Shape, and Symmetry
  1623. Abnormalities of Head Shape
  1624. Perinatal Birth Injuries to Head and Neck
  1625. Neonatal Eye Disorders
  1626. Disorders of the Neonatal Nose and Mouth
  1627. NEONATAL CARDIAC EMERGENCIES
  1628. Current Evidence
  1629. Goals of Treatment
  1630. Clinical Considerations
  1631. NEONATAL RESPIRATORY AND AIRWAY PROBLEMS
  1632. Goals of Emergency Care
  1633. Diseases That Cause Stridor in a Neonate
  1634. Other Disorders That Produce Neonatal Respiratory Distress
  1635. ABDOMINAL, GASTROINTESTINAL, AND GENITOURINARY EMERGENCIES
  1636. Goals of Treatment
  1637. Malrotation and Volvulus
  1638. Other Causes of Intestinal Obstruction
  1639. Necrotizing Enterocolitis
  1640. Hernias
  1641. Umbilical Cord Anomalies
  1642. Abnormal Stool
  1643. Abdominal Masses
  1644. Genitourinary Anomalies
  1645. NEONATAL NEUROLOGIC EMERGENCIES
  1646. Goals of Treatment
  1647. Seizures
  1648. Neonatal Encephalopathy
  1649. Neonatal Abstinence Syndrome
  1650. Abnormal Tone
  1651. NEONATAL INFECTIONS
  1652. Goals of Treatment
  1653. Neonatal Sepsis
  1654. Pneumonia in the Newborn
  1655. Urinary Tract Infections in the Newborn
  1656. Other Viral Infections of the Newborn
  1657. Neonatal Herpes Simplex Virus Infection
  1658. Neonatal Enteroviral Infection
  1659. Special Considerations
  1660. CHAPTER 97: NEUROLOGIC EMERGENCIES
  1661. GOALS OF EMERGENCY CARE
  1662. SEIZURES (SEE ALSO CHAPTER 72 SEIZURES)
  1663. Goals of Treatment
  1664. Current Evidence
  1665. Clinical Considerations
  1666. DISORDERS THAT PRESENT WITH HEADACHE (SEE ALSO CHAPTER 59 PAIN: HEADACHE)
  1667. Migraine
  1668. Idiopathic Intracranial Hypertension (Pseudotumor Cerebri)
  1669. STROKE/CEREBROVASCULAR ACCIDENT
  1670. Goals of Treatment
  1671. Current Evidence
  1672. Clinical Considerations
  1673. DISORDERS THAT PRESENT WITH ENCEPHALOPATHY (SEE ALSO CHAPTER 17 COMA)
  1674. Goals of Treatment
  1675. DISORDERS OF MOTOR FUNCTION (SEE ALSO CHAPTER 82 WEAKNESS)
  1676. Goals of Treatment
  1677. DISORDERS OF BALANCE (SEE CHAPTERS 15 ACUTE ATAXIA AND 24 DIZZINESS AND VERTIGO)
  1678. Goals of Treatment
  1679. MOVEMENT DISORDERS
  1680. Goals of Treatment
  1681. DISORDERS OF CRANIAL NERVE FUNCTION
  1682. Goals of Treatment
  1683. CHAPTER 98: ONCOLOGIC EMERGENCIES
  1684. GOALS OF EMERGENCY THERAPY
  1685. SECTION I: INITIAL CARE OF THE CHILD WITH NEW OR RECURRENT CANCER
  1686. LEUKEMIA
  1687. Goals of Treatment
  1688. Current Evidence
  1689. Clinical Considerations
  1690. HISTIOCYTIC DISEASES
  1691. Goal of Treatment
  1692. Current Evidence
  1693. Clinical Considerations
  1694. TUMORS OF THE CENTRAL NERVOUS SYSTEM
  1695. Goals of Treatment
  1696. Current Evidence
  1697. Clinical Considerations
  1698. TUMORS OF THE HEAD AND NECK
  1699. Goals of Treatment
  1700. Current Evidence
  1701. Clinical Considerations
  1702. TUMORS OF THE THORAX
  1703. Goals of Treatment
  1704. Current Evidence
  1705. Clinical Considerations
  1706. TUMORS OF THE HEPATOBILIARY TREE
  1707. Goals of Treatment
  1708. Current Evidence
  1709. Clinical Considerations
  1710. Tumors of the Pancreas
  1711. Tumors of the Gastrointestinal Tract
  1712. NEUROBLASTOMA
  1713. Goals of Treatment
  1714. Current Evidence
  1715. Clinical Considerations
  1716. TUMORS OF THE KIDNEY
  1717. Goals of Treatment
  1718. Current Evidence
  1719. Clinical Considerations
  1720. TUMORS OF THE LOWER GENITOURINARY TRACT
  1721. GONADAL TUMORS
  1722. TUMORS IN AND AROUND THE SPINAL CORD
  1723. TUMORS OF BONE
  1724. Goal of Treatment
  1725. Current Evidence
  1726. Clinical Considerations
  1727. TUMORS OF THE SOFT TISSUES
  1728. CANCERS OF THE SKIN
  1729. SECTION II: MANAGEMENT OF COMPLICATIONS ASSOCIATED WITH CANCER AND CANCER THERAPY
  1730. HEMATOLOGIC COMPLICATIONS OF CANCER TREATMENT
  1731. Goals of Treatment
  1732. Current Evidence
  1733. Clinical Considerations
  1734. INFECTIOUS COMPLICATIONS OF CANCER TREATMENT
  1735. Goals of Treatment
  1736. Current Evidence
  1737. Clinical Considerations
  1738. COMPLICATIONS OF CAR-T CELL THERAPY
  1739. Goals of Treatment
  1740. Current Evidence
  1741. Clinical Considerations
  1742. METABOLIC COMPLICATIONS OF CANCER TREATMENT
  1743. PAIN
  1744. Goals of Treatment
  1745. Current Evidence
  1746. Clinical Considerations
  1747. NEUROLOGIC COMPLICATIONS OF CANCER TREATMENT
  1748. CARDIOVASCULAR COMPLICATIONS
  1749. HEPATIC AND GASTROINTESTINAL COMPLICATIONS OF CANCER TREATMENT
  1750. RENAL COMPLICATIONS OF CANCER THERAPY
  1751. GENITOURINARY COMPLICATIONS OF CANCER TREATMENT
  1752. SKIN COMPLICATIONS OF CANCER TREATMENT
  1753. COMPLICATIONS OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
  1754. CARE OF PATIENTS WITH ADVANCED CANCER
  1755. CHAPTER 99: PULMONARY EMERGENCIES
  1756. GOALS OF EMERGENCY THERAPY
  1757. ACUTE RESPIRATORY FAILURE
  1758. Current Evidence
  1759. Goals of Treatment
  1760. Clinical Considerations
  1761. ASTHMA
  1762. Current Evidence
  1763. Goals of Treatment
  1764. Clinical Considerations
  1765. ASPIRATION PNEUMONIA
  1766. Current Evidence
  1767. Goal of Treatment
  1768. Clinical Considerations
  1769. BRONCHOPULMONARY DYSPLASIA
  1770. Current Evidence
  1771. Goals of Treatment
  1772. Clinical Considerations
  1773. CYSTIC FIBROSIS
  1774. Current Evidence
  1775. Goals of Treatment
  1776. Clinical Considerations
  1777. PULMONARY HEMORRHAGE
  1778. Current Evidence
  1779. Goals of Treatment
  1780. Clinical Considerations
  1781. PULMONARY EMBOLISM
  1782. Current Evidence
  1783. Goals of Treatment
  1784. Clinical Considerations
  1785. PULMONARY EDEMA
  1786. Current Evidence
  1787. Goals of Treatment
  1788. Clinical Considerations
  1789. PLEURITIS/PLEURAL EFFUSION
  1790. Current Evidence
  1791. Goals of Treatment
  1792. Clinical Considerations
  1793. SARCOIDOSIS
  1794. Current Evidence
  1795. Goals of Treatment
  1796. Clinical Considerations
  1797. OBSTRUCTIVE SLEEP APNEA
  1798. Current Evidence
  1799. Goals of Treatment
  1800. Clinical Considerations
  1801. INTERSTITIAL LUNG DISEASE
  1802. CHAPTER 100: RENAL AND ELECTROLYTE EMERGENCIES
  1803. GOALS OF EMERGENCY CARE
  1804. DEHYDRATION/HYPOVOLEMIA
  1805. Current Evidence
  1806. Goals of Treatment
  1807. Clinical Considerations
  1808. DISORDERS OF SODIUM HOMEOSTASIS
  1809. Goals of Treatment
  1810. Hyponatremia
  1811. Hypernatremia
  1812. DISORDERS OF POTASSIUM HOMEOSTASIS
  1813. Goals of Treatment
  1814. Hypokalemia
  1815. Hyperkalemia
  1816. DISORDERS OF CALCIUM HOMEOSTASIS
  1817. Goals of Treatment
  1818. Hypocalcemia
  1819. Hypercalcemia
  1820. DISORDERS OF ACID–BASE HOMEOSTASIS
  1821. Goals of Treatment
  1822. Metabolic Acidosis
  1823. Metabolic Alkalosis
  1824. ACUTE KIDNEY INJURY
  1825. Current Evidence
  1826. Goals of Treatment
  1827. Clinical Considerations
  1828. INTRINSIC CAUSES OF AKI
  1829. Hemolytic Uremic Syndrome
  1830. Postinfectious Glomerulonephritis
  1831. Henoch–Schönlein Purpura
  1832. Acute Interstitial Nephritis
  1833. Rhabdomyolysis
  1834. NEPHROTIC SYNDROME
  1835. Current Evidence
  1836. Goals of Treatment
  1837. Clinical Considerations
  1838. CHRONIC KIDNEY DISEASE
  1839. Current Evidence
  1840. Goals of Treatment
  1841. Clinical Considerations
  1842. CHAPTER 101: RHEUMATOLOGIC EMERGENCIES
  1843. GOALS OF EMERGENCY CARE
  1844. SYSTEMIC LUPUS ERYTHEMATOSUS
  1845. Current Evidence
  1846. Goals of Treatment
  1847. Clinical Considerations
  1848. OTHER SYSTEMIC CONNECTIVE TISSUE DISEASES
  1849. Scleroderma and Mixed Connective Tissue Disease
  1850. Scleroderma
  1851. Mixed Connective Tissue Disease
  1852. VASCULITIS
  1853. Current Evidence
  1854. Goals of Treatment
  1855. Clinical Considerations
  1856. POLYARTERITIS NODOSA
  1857. Current Evidence
  1858. Clinical Considerations
  1859. JUVENILE DERMATOMYOSITIS
  1860. Current Evidence
  1861. Clinical Considerations
  1862. Management
  1863. BEHÇET DISEASE
  1864. Clinical Considerations
  1865. Management
  1866. ARTHRITIS
  1867. JUVENILE IDIOPATHIC ARTHRITIS
  1868. Current Evidence
  1869. Clinical Considerations
  1870. Laboratory and Radiologic Features
  1871. Management
  1872. HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND MACROPHAGE ACTIVATION SYNDROME
  1873. Current Evidence
  1874. Clinical Considerations
  1875. Management
  1876. KAWASAKI DISEASE
  1877. Current Evidence
  1878. Goals of Treatment
  1879. Clinical Considerations
  1880. Management
  1881. LYME DISEASE
  1882. CHAPTER 102: TOXICOLOGIC EMERGENCIES
  1883. PEDIATRIC POISONINGS
  1884. Current Evidence
  1885. CLINICAL CONSIDERATIONS
  1886. Initial Life Support Phase
  1887. Evaluation and Detoxification Phase
  1888. NONTOXIC INGESTION
  1889. PHARMACEUTICALS
  1890. Acetaminophen
  1891. Cardiac Drugs
  1892. Iron
  1893. Psychotropic Medications
  1894. Salicylates
  1895. Miscellaneous Toxins
  1896. Drugs Dangerous in Small Doses
  1897. NONPHARMACEUTICALS
  1898. Alcohols and Glycols
  1899. Foods/Fish
  1900. HOUSEHOLD CLEANING PRODUCTS AND CAUSTICS
  1901. Household Cleaning Products
  1902. Pesticides
  1903. Rodenticides
  1904. PLANTS/MUSHROOMS
  1905. Plant Toxicity
  1906. Mushrooms
  1907. SUBSTANCE USE
  1908. Current Evidence
  1909. Clinical Considerations
  1910. Clinical Indications for Discharge or Admission
  1911. SPECIFIC DRUGS
  1912. Psychoactives, Including Novel Psychoactives
  1913. Cannabis and Synthetic Cannabinoid Receptor Antagonists
  1914. STIMULANTS
  1915. Amphetamines
  1916. Cocaine
  1917. Central Anticholinergics
  1918. Central Nervous System Sedative-Hypnotics
  1919. Opioids
  1920. γ-Hydroxybutyrate, γ-Hydroxybutyrolactone, and 1,4-Butanediol
  1921. Inhalants
  1922. OTHER EMERGING DRUGS OF ABUSE
  1923. Current Evidence
  1924. Cathinones
  1925. SECTION V: Trauma
  1926. CHAPTER 103: ABDOMINAL TRAUMA
  1927. GOALS OF EMERGENCY CARE
  1928. THE APPROACH TO THE PEDIATRIC PATIENT WITH ABDOMINAL TRAUMA
  1929. Current Evidence
  1930. Goals of Treatment
  1931. Clinical Considerations
  1932. FOCUSED ABDOMINAL SONOGRAPHY FOR TRAUMA
  1933. Goals of Treatment
  1934. DIAGNOSTIC IMAGING FOR ABDOMINAL TRAUMA
  1935. Goals of Treatment
  1936. EMERGENT VERSUS SELECTIVE LAPAROSCOPY OR LAPAROTOMY
  1937. Goals of Treatment
  1938. BLUNT ABDOMINAL TRAUMA
  1939. Goals of Treatment
  1940. Abdominal Wall Contusions
  1941. Solid Organ Injuries
  1942. Pancreatic Injuries
  1943. Hollow Abdominal Viscera Injuries
  1944. Late Presentations of Intra-Abdominal Trauma
  1945. PENETRATING ABDOMINAL TRAUMA
  1946. Goals of Treatment
  1947. Gunshot Wounds
  1948. Stab Wounds
  1949. ABDOMINAL INJURIES—THE LAP BELT COMPLEX AND CHILD ABUSE
  1950. Goals of Treatment
  1951. LAP AND SHOULDER BELT AND AIR BAG INJURIES
  1952. Child Abuse
  1953. CHAPTER 104: BURNS
  1954. GOALS OF EMERGENCY CARE
  1955. INITIAL ASSESSMENT AND RESUSCITATION
  1956. Current Evidence
  1957. Goals of Treatment
  1958. Clinical Considerations
  1959. MAJOR BURNS
  1960. Current Evidence
  1961. Goals of Treatment
  1962. Clinical Considerations
  1963. MINOR BURNS
  1964. Goals of Treatment
  1965. Clinical Considerations
  1966. SPECIAL CIRCUMSTANCES
  1967. Goals of Treatment
  1968. Inflicted Burns
  1969. Electrical Burns
  1970. Chemical Burns
  1971. CHAPTER 105: DENTAL TRAUMA
  1972. GOALS OF EMERGENCY CARE
  1973. ASSESSMENT OF TRAUMATIC DENTAL EMERGENCIES
  1974. Current Evidence
  1975. Goals of Treatment
  1976. Clinical Considerations
  1977. SOFT TISSUE INJURY
  1978. Current Evidence
  1979. Goals of Treatment
  1980. Clinical Considerations
  1981. TRAUMATIC DENTAL INJURIES
  1982. Current Evidence
  1983. Goals of Treatment
  1984. Clinical Considerations
  1985. JAW FRACTURES
  1986. Current Evidence
  1987. Goals of Treatment
  1988. Mandibular Fractures/Dislocations
  1989. Maxillary Fractures
  1990. CHAPTER 106: ENT TRAUMA
  1991. GOALS OF EMERGENCY THERAPY
  1992. General Goals
  1993. TRAUMA TO THE EAR
  1994. Ear Foreign Body
  1995. Current Evidence
  1996. Clinical Considerations
  1997. Ear Trauma
  1998. EXTERNAL EAR
  1999. Current Evidence
  2000. Clinical Considerations
  2001. MIDDLE EAR
  2002. Current Evidence
  2003. Clinical Considerations
  2004. INNER EAR
  2005. Current Evidence
  2006. Clinical Considerations
  2007. OTHER INJURIES ASSOCIATED WITH EAR TRAUMA
  2008. Temporal Bone Fracture
  2009. CSF Otorrhea
  2010. TRAUMA TO THE NOSE AND SINUSES
  2011. Nasal Foreign Body
  2012. Current Evidence
  2013. Clinical Considerations
  2014. Trauma to the Nose and Sinuses
  2015. Current Evidence
  2016. Clinical Considerations
  2017. Sinus Barotrauma
  2018. TRAUMA TO THE ORAL CAVITY AND PHARYNX
  2019. Goals of Treatment
  2020. Current Evidence
  2021. Clinical Considerations
  2022. Caustic Injuries
  2023. TRAUMA TO THE LARYNX AND TRACHEA
  2024. Foreign Body
  2025. Current Evidence
  2026. Clinical Considerations
  2027. LARYNGEAL AND TRACHEAL TRAUMA
  2028. Goals of Treatment
  2029. Current Evidence
  2030. Clinical Considerations
  2031. CHAPTER 107: FACIAL TRAUMA
  2032. GOALS OF EMERGENCY THERAPY
  2033. Stabilization of the Airway
  2034. Cervical Spine Protection
  2035. Identification of Specific Bony Injuries and Facial Neurologic Deficits
  2036. Determination of Appropriate Imaging Modality
  2037. Obtain Subspecialty Consultation When Indicated
  2038. FACIAL FRACTURES
  2039. Mandible Fracture
  2040. Orbital Fracture
  2041. Nasal Fracture
  2042. Zygoma and Maxilla Fractures
  2043. Frontal Bone Fractures
  2044. SOFT TISSUE INJURIES
  2045. Lacerations
  2046. Regional Nerve Blocks
  2047. Guidelines for Subspecialty Consultation
  2048. CHAPTER 108: GENITOURINARY TRAUMA
  2049. INTRODUCTION
  2050. GOALS OF EMERGENCY THERAPY
  2051. KIDNEY
  2052. Goal of Treatment
  2053. Current Evidence
  2054. Clinical Considerations
  2055. Initial Assessment
  2056. Management/Diagnostic Testing
  2057. Clinical Indications for Discharge or Admission
  2058. URETER
  2059. Goal of Treatment
  2060. Current Evidence
  2061. Clinical Considerations
  2062. Management/Diagnostic Testing
  2063. Clinical Indications for Discharge or Admission
  2064. BLADDER
  2065. Goal of Treatment
  2066. Current Evidence
  2067. Clinical Considerations
  2068. Initial Assessment/Diagnostic Testing
  2069. Management
  2070. Clinical Indications for Discharge or Admission
  2071. URETHRA
  2072. Goal of Treatment
  2073. Current Evidence
  2074. Clinical Considerations
  2075. Management
  2076. Clinical Indications for Discharge or Admission
  2077. SCROTUM
  2078. Goal of Treatment
  2079. Clinical Considerations
  2080. Initial Assessment, Management, and Diagnostic Testing
  2081. PENIS
  2082. Clinical Recognition
  2083. PERINEUM
  2084. SEXUAL ABUSE
  2085. CHAPTER 109: HAND TRAUMA
  2086. GOALS OF EMERGENCY CARE
  2087. FINGERTIP INJURIES
  2088. Clinical Considerations
  2089. HAND LACERATIONS
  2090. Clinical Considerations
  2091. PHALANGES
  2092. Clinical Considerations
  2093. DISLOCATIONS
  2094. Clinical Considerations
  2095. METACARPALS
  2096. Clinical Considerations
  2097. CARPALS
  2098. Clinical Considerations
  2099. CHAPTER 110: MINOR TRAUMA
  2100. GOALS OF EMERGENCY CARE
  2101. GENERAL PRINCIPLES OF MINOR WOUND REPAIR
  2102. Obtaining Hemostasis
  2103. Prevention of Infection
  2104. Cosmesis and Wound Healing
  2105. Parental Satisfaction
  2106. Rate of Wound Infection After Repair
  2107. Current Evidence
  2108. Clinical Considerations
  2109. Painless Alternatives to Sutures
  2110. Wound Care
  2111. Wound Aftercare
  2112. MANAGEMENT OF SPECIFIC WOUNDS
  2113. Facial and Oral Wounds
  2114. Forehead Lacerations
  2115. Eyebrow Lacerations
  2116. Eyelid Lacerations
  2117. External Ear Blunt Trauma and Lacerations
  2118. Nasal Lacerations
  2119. Lip Lacerations
  2120. Cheek Lacerations
  2121. Tongue Lacerations
  2122. Buccal Mucosa Lacerations
  2123. FINGERTIP
  2124. Fingertip Avulsion
  2125. Nail Bed Lacerations
  2126. Subungual Hematoma
  2127. GENITOURINARY LACERATIONS
  2128. VASCULAR INJURIES
  2129. LACERATIONS IN PROXIMITY TO JOINTS
  2130. CHAPTER 111: MUSCULOSKELETAL TRAUMA
  2131. GENERAL PRINCIPLES OF PEDIATRIC ORTHOPEDICS
  2132. Goals of Emergency Therapy
  2133. GENERAL PRINCIPLES AND PROPERTIES OF PEDIATRIC FRACTURES
  2134. Goals of Treatment
  2135. Anatomy and Physiology of Pediatric Bone
  2136. Physeal Fractures
  2137. Torus Fractures
  2138. Greenstick Fractures
  2139. Bowing Fractures
  2140. Avulsion Fractures
  2141. GENERAL PRINCIPLES OF ACUTE ORTHOPEDIC CARE
  2142. Current Evidence
  2143. Goals of Treatment
  2144. Clinical Considerations
  2145. COMPLICATIONS OF FRACTURES: OPEN FRACTURES AND COMPARTMENT SYNDROME
  2146. Goals of Treatment
  2147. Current Evidence
  2148. Clinical Considerations
  2149. MULTIPLE TRAUMA
  2150. PHYSICAL ABUSE
  2151. PATHOLOGIC FRACTURES
  2152. INJURIES OF THE UPPER EXTREMITIES
  2153. Injuries of the Shoulder and Humerus
  2154. Shoulder Dislocation
  2155. Injuries of the Scapula
  2156. Injuries of the Humerus
  2157. Injuries of the Elbow
  2158. Lateral Condyle Fractures
  2159. Medial Epicondyle Fractures
  2160. Distal Humerus Physeal Fractures
  2161. Olecranon Fractures
  2162. Radial Head and Neck Fractures
  2163. Elbow Dislocations
  2164. Radial Head Subluxation
  2165. Injuries of the Forearm
  2166. Fractures of the Distal Radius and Ulna
  2167. INJURIES OF THE LOWER EXTREMITIES
  2168. Injuries of the Pelvis and Hip
  2169. Injuries of the Hip and Proximal Femur
  2170. Injuries of the Femur and Knee
  2171. Injuries of the Knee
  2172. Injuries of the Proximal Tibia and Fibula and Shaft
  2173. Injuries of the Ankle and Foot
  2174. Injuries of the Foot
  2175. INJURIES OF THE THORACOLUMBAR SPINE
  2176. Goals of Treatment
  2177. Current Evidence
  2178. Clinical Considerations
  2179. CHAPTER 112: NECK TRAUMA
  2180. GOALS OF EMERGENCY CARE
  2181. PENETRATING TRAUMA
  2182. Goals of Treatment
  2183. Current Evidence
  2184. Clinical Considerations
  2185. BLUNT TRAUMA
  2186. Goals of Treatment
  2187. Current Evidence
  2188. Clinical Considerations
  2189. CERVICAL SPINE TRAUMA
  2190. Goals of Treatment
  2191. Current Evidence
  2192. Clinical Considerations
  2193. SPECIFIC INJURIES
  2194. Jefferson Fracture
  2195. Hangman’s Fracture
  2196. Atlantoaxial Subluxation
  2197. Cervical Distraction Injuries
  2198. Vertebral Compression Injuries
  2199. Spinal Cord Injury Without Radiographic Abnormality
  2200. Torticollis (Wry Neck)
  2201. Spinal Cord Syndromes
  2202. CHAPTER 113: NEUROTRAUMA
  2203. GOALS OF EMERGENCY THERAPY
  2204. NEUROTRAUMA
  2205. Blunt Head Injury
  2206. CONCUSSION
  2207. Current Evidence
  2208. SKULL FRACTURES
  2209. Goal of Treatment
  2210. Clinical Considerations
  2211. CHAPTER 114: OCULAR TRAUMA
  2212. GOALS OF EMERGENCY CARE
  2213. HISTORY
  2214. Assessment of Prior Eye Pathology and Relevant Medical History
  2215. Assessment of Injury Mechanism
  2216. PHYSICAL EXAMINATION
  2217. Assess Visual Acuity
  2218. Inspect the Periorbital Tissues and Eyelids Thoroughly
  2219. Open the Eyelids
  2220. Check the Red Reflex
  2221. Evaluate the Pupils and the Extraocular Movements
  2222. Evaluate the Anterior Surface of the Eye
  2223. Perform Direct Ophthalmoscopy to Evaluate for Papilledema or Retinal Hemorrhages
  2224. Consider Bedside Ultrasound
  2225. OPEN-GLOBE INJURY
  2226. Current Evidence
  2227. Goals of Treatment
  2228. Clinical Considerations
  2229. BLOW-OUT FRACTURE
  2230. Current Evidence
  2231. Goals of Treatment
  2232. Clinical Considerations
  2233. EYELID LACERATIONS
  2234. Current Evidence
  2235. Goals of Treatment
  2236. Clinical Considerations
  2237. CORNEAL AND CONJUNCTIVAL INJURY
  2238. Current Evidence
  2239. Goals of Treatment
  2240. Clinical Considerations
  2241. HYPHEMA
  2242. Current Evidence
  2243. Goals of Treatment
  2244. Clinical Considerations
  2245. TRAUMATIC IRITIS
  2246. Clinical Manifestations
  2247. Management
  2248. Traumatic Versus Nonorganic Visual Loss
  2249. Child Abuse
  2250. CHAPTER 115: THORACIC TRAUMA
  2251. GOALS OF EMERGENCY THERAPY
  2252. PNEUMOTHORAX AND HEMOTHORAX
  2253. Current Evidence
  2254. Goals of Treatment
  2255. Clinical Considerations
  2256. Diagnostic Testing
  2257. Management
  2258. Disposition
  2259. PULMONARY CONTUSIONS
  2260. Current Evidence
  2261. Clinical Considerations
  2262. Disposition
  2263. BLUNT CARDIAC INJURIES
  2264. Current Evidence
  2265. Clinical Considerations
  2266. INJURIES OF THE AORTA AND GREAT VESSELS
  2267. Current Evidence
  2268. Clinical Considerations
  2269. CHEST WALL INJURIES
  2270. Goals of Treatment
  2271. RIB FRACTURES
  2272. RIB FRACTURES AND CHILD ABUSE
  2273. FLAIL CHEST
  2274. STERNAL, SCAPULAR, AND MEDIAL CLAVICLE FRACTURES
  2275. PENETRATING TRAUMA AND ED THORACOTOMY
  2276. Goals of Treatment
  2277. Emergency Thoracotomy
  2278. OTHER INTRATHORACIC INJURIES
  2279. Goals of Treatment
  2280. Tracheobronchial Injuries
  2281. ESOPHAGEAL INJURIES
  2282. DIAPHRAGMATIC INJURIES
  2283. TRAUMATIC ASPHYXIA
  2284. SECTION VI: Surgical Emergencies
  2285. CHAPTER 116: ABDOMINAL EMERGENCIES
  2286. GOALS OF EMERGENCY CARE
  2287. ACUTE NONPERFORATED APPENDICITIS
  2288. Current Evidence
  2289. Goals of Treatment
  2290. Clinical Considerations
  2291. PERFORATED APPENDICITIS
  2292. Goals of Treatment
  2293. Clinical Considerations
  2294. ACUTE INTESTINAL OBSTRUCTION
  2295. Goals of Treatment
  2296. Current Evidence
  2297. Intussusception
  2298. Incarcerated Inguinal Hernia
  2299. Incarcerated Umbilical Hernia
  2300. Malrotation of the Bowel With Volvulus
  2301. Sigmoid Volvulus
  2302. Pyloric Stenosis
  2303. Postoperative Adhesions
  2304. Chronic Partial Intestinal Obstruction
  2305. Chronic Constipation
  2306. Aganglionic Megacolon (Hirschsprung Disease)
  2307. Duplications
  2308. Inflammatory Bowel Disease
  2309. DISEASES THAT PRODUCE RECTAL BLEEDING
  2310. Goals of Treatment
  2311. Fissures
  2312. Juvenile Polyps
  2313. Meckel Diverticulum
  2314. INTRA-ABDOMINAL MASSES
  2315. Current Evidence
  2316. Sacrococcygeal Teratoma
  2317. Nonmalignant Intra-Abdominal Masses
  2318. Malignant Intra-Abdominal Masses
  2319. ABDOMINAL WALL DEFECTS
  2320. Inguinal Hernias and Hydroceles
  2321. Epiploceles (Epigastric Hernias)
  2322. Umbilical Hernias
  2323. Other Umbilical Defects
  2324. CHAPTER 117: DENTAL EMERGENCIES
  2325. GOALS OF THERAPY
  2326. Odontalgia—Simple Toothache
  2327. Dentoalveolar Infection and Abscess
  2328. POSTEXTRACTION COMPLICATIONS
  2329. Goals of Treatment
  2330. Hemorrhage
  2331. Infection
  2332. Alveolar Osteitis
  2333. PERIODONTAL SOFT TISSUE PATHOLOGY
  2334. Goals of Treatment
  2335. Pericoronitis
  2336. Acute Necrotizing Ulcerative Gingivitis, Trench Mouth
  2337. Primary Herpetic Gingivostomatitis or Herpes Simplex Virus Type 1
  2338. ORAL MUCOSAL SOFT TISSUE PATHOLOGY
  2339. Goals of Treatment
  2340. Eruption Cysts
  2341. Aphthous Stomatitis
  2342. Mucocele
  2343. Pyogenic Granuloma
  2344. Neonatal Cysts
  2345. Riga–Fede Disease/Natal or Neonatal Teeth
  2346. CHAPTER 118: ENT EMERGENCIES
  2347. GOALS OF EMERGENCY CARE
  2348. ACUTE OTITIS MEDIA
  2349. Goals of Treatment
  2350. Current Evidence
  2351. Clinical Considerations
  2352. SINUSITIS
  2353. Goals of Treatment
  2354. Current Evidence
  2355. Clinical Considerations
  2356. TONSILLITIS AND PERITONSILLAR ABSCESS/CELLULITIS
  2357. Goals of Treatment
  2358. Current Evidence
  2359. Clinical Considerations
  2360. RETROPHARYNGEAL AND PARAPHARYNGEAL INFECTIONS
  2361. Goals of Treatment
  2362. Current Evidence
  2363. Clinical Considerations
  2364. CERVICAL ADENITIS AND NECK ABSCESSES
  2365. Goals of Treatment
  2366. Current Evidence
  2367. Clinical Considerations
  2368. POSTTONSILLECTOMY HEMORRHAGE
  2369. Goals of Treatment
  2370. Current Evidence
  2371. Clinical Considerations
  2372. VERTIGO
  2373. Goals of Treatment
  2374. OTHER CONDITIONS OF THE EXTERNAL EAR
  2375. Goals of Treatment
  2376. EPISTAXIS
  2377. Goals of Treatment
  2378. CONDITIONS OF THE LARYNX AND TRACHEA
  2379. Goals of Treatment
  2380. CHAPTER 119: GENITOURINARY EMERGENCIES
  2381. GOALS OF EMERGENCY CARE
  2382. PENILE PROBLEMS
  2383. Penile Care in the Uncircumcised Male Infant
  2384. Post Circumcision Concerns
  2385. Phimosis and Paraphimosis
  2386. Meatal Stenosis
  2387. Balanoposthitis
  2388. Priapism
  2389. TESTICULAR PROBLEMS
  2390. Background
  2391. Testicular Torsion
  2392. Testicular Mass
  2393. Torsion of the Appendix Testis
  2394. Epididymitis
  2395. Hydrocele
  2396. Undescended Testis
  2397. Varicocele
  2398. FEMALE UROLOGIC EMERGENCIES
  2399. Goals of Treatment
  2400. Clinical Recognition
  2401. Clinical Assessment
  2402. Management
  2403. RENAL COLIC/NEPHROLITHIASIS
  2404. Goals of Treatment
  2405. Clinical Recognition
  2406. Triage Considerations
  2407. Management
  2408. ACUTE URINARY RETENTION
  2409. Background
  2410. Goals of Treatment
  2411. Clinical Recognition
  2412. Triage Considerations
  2413. Clinical Assessment
  2414. Management
  2415. CHAPTER 120: MINOR LESIONS
  2416. GOALS OF EMERGENCY CARE
  2417. HAND AND FOOT LESIONS
  2418. Eponychia and Paronychia
  2419. Herpetic Whitlow
  2420. Felon
  2421. Subungual Hematoma
  2422. Subungual Foreign Body
  2423. Hair Tourniquet
  2424. Ganglion
  2425. FACE AND SCALP LESIONS
  2426. Epidermal Inclusion Cyst
  2427. Dermoid Cyst
  2428. Nasal Bridge Lesions
  2429. Preauricular Lesions
  2430. NECK LESIONS
  2431. Midline Neck Lesions
  2432. Lateral Neck Lesions
  2433. SURFACE LESIONS
  2434. Vascular Malformations
  2435. CHAPTER 121: MUSCULOSKELETAL EMERGENCIES
  2436. GOALS OF EMERGENCY CARE
  2437. OSTEOMYELITIS
  2438. Current Evidence
  2439. Goals of Treatment
  2440. Clinical Considerations
  2441. SEPTIC ARTHRITIS
  2442. Goals of Treatment
  2443. Current Evidence
  2444. Clinical Considerations
  2445. Lyme Arthritis
  2446. Transient Synovitis
  2447. Penetrating Intra-Articular Wounds
  2448. OVERUSE SYNDROMES
  2449. Goals of Treatment
  2450. Current Evidence
  2451. Osgood–Schlatter Disease
  2452. Sinding-Larsen–Johansson Disease
  2453. Little Leaguer Elbow
  2454. Sever Disease
  2455. Bursitis
  2456. OSTEOCHONDRITIS DISSECANS
  2457. Current Evidence
  2458. Clinical Considerations
  2459. SLIPPED CAPITAL FEMORAL EPIPHYSIS
  2460. Goals of Treatment
  2461. Current Evidence
  2462. Clinical Considerations
  2463. PATELLOFEMORAL PAIN SYNDROME AND CHONDROMALACIA PATELLAE
  2464. Current Evidence
  2465. Clinical Considerations
  2466. LEGG–CALVé–PERTHES DISEASE
  2467. Current Evidence
  2468. Clinical Considerations
  2469. ANNULAR LIGAMENT DISPLACEMENT (RADIAL HEAD SUBLUXATION)
  2470. Current Evidence
  2471. Clinical Considerations
  2472. Shoulder (Glenohumeral) Subluxation/Dislocation
  2473. DISORDERS OF THE BACK
  2474. Discitis (Diskitis)
  2475. Spondylolysis and Spondylolisthesis
  2476. COMPARTMENT SYNDROME
  2477. Current Evidence
  2478. Clinical Considerations
  2479. COMPLEX REGIONAL PAIN SYNDROME TYPE 1 (REFLEX SYMPATHETIC DYSTROPHY)
  2480. Current Evidence
  2481. Clinical Considerations
  2482. CHAPTER 122: NEUROSURGICAL EMERGENCIES
  2483. GOALS OF EMERGENCY THERAPY
  2484. SPONTANEOUS (NONTRAUMATIC) INTRACEREBRAL HEMORRHAGE
  2485. Goals of Treatment
  2486. Clinical Considerations
  2487. ACUTE HYDROCEPHALUS
  2488. Goals of Treatment
  2489. Clinical Considerations
  2490. SHUNT FAILURE
  2491. Goals of Treatment
  2492. Clinical Considerations
  2493. SPINAL HEMORRHAGE
  2494. CENTRAL NERVOUS SYSTEM INFECTION
  2495. Meningitis
  2496. Discitis/Osteomyelitis
  2497. POSTOPERATIVE COMPLICATIONS
  2498. Mass Lesions
  2499. Hydrocephalus
  2500. CHAPTER 123: OPHTHALMIC EMERGENCIES
  2501. GOALS OF EMERGENCY CARE
  2502. EXAMINATION
  2503. Assessment of Ocular Positioning and Movement
  2504. Visual Acuity Testing
  2505. Examining the Swollen Eye
  2506. Instillation of Eye Drops
  2507. COMMON EYE EMERGENCIES
  2508. Periorbital and Orbital Cellulitis
  2509. Conjunctivitis
  2510. Ocular Chemical Injury
  2511. Hordeolums and Chalazions
  2512. Nasolacrimal Duct Obstruction and Infection
  2513. CHAPTER 124: THORACIC EMERGENCIES
  2514. INTRODUCTION
  2515. GOALS OF EMERGENCY THERAPY
  2516. CLINICAL MANIFESTATIONS
  2517. Physical Examination
  2518. Evaluation
  2519. AIRWAY COMPROMISE
  2520. Tracheal Obstruction
  2521. Tracheomalacia
  2522. Vascular Rings
  2523. BRONCHIAL LESIONS
  2524. Bronchial Atresia
  2525. Primary Tracheobronchial Tumors
  2526. Right Middle Lobe Syndrome
  2527. ESOPHAGUS-RELATED CAUSES OF AIRWAY DIFFICULTIES
  2528. Goal of Treatment
  2529. Esophageal Atresia and Tracheoesophageal Fistula
  2530. Esophageal Web
  2531. Caustic Ingestion
  2532. PLEURAL DISEASES
  2533. Pneumothorax
  2534. Pneumomediastinum
  2535. Pleural Effusion
  2536. Empyema
  2537. Solid Lung and Pleural Lesions
  2538. LUNG LESIONS
  2539. Current Evidence
  2540. Goal of Treatment
  2541. Cystic Lung Disorders—CPAM and BPS
  2542. Bronchogenic Cyst
  2543. Congenital Lobar Emphysema
  2544. Congenital Pulmonary Arteriovenous Fistula
  2545. Rare Lesions
  2546. MEDIASTINAL TUMORS
  2547. Current Evidence
  2548. Goal of Treatment
  2549. Clinical Considerations
  2550. Solid Mediastinal Masses
  2551. Cystic Mediastinal Lesions
  2552. DIAPHRAGMATIC PROBLEMS
  2553. Current Evidence
  2554. Goal of Treatment
  2555. Congenital Diaphragmatic Hernia
  2556. Foramen of Morgagni Hernias
  2557. Diaphragmatic Eventration
  2558. Paraesophageal Hernia
  2559. CHEST WALL TUMORS
  2560. Current Evidence
  2561. Goals of Treatment
  2562. Clinical Considerations
  2563. CHAPTER 125: TRANSPLANTATION EMERGENCIES
  2564. GOALS OF EMERGENCY CARE
  2565. POSTTRANSPLANT INFECTIOUS COMPLICATIONS
  2566. Current Evidence
  2567. Goals of Treatment
  2568. Clinical Considerations
  2569. GRAFT REJECTION
  2570. Current Evidence
  2571. Goals of Treatment
  2572. Clinical Considerations
  2573. POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER
  2574. Goals of Treatment
  2575. Current Evidence
  2576. Clinical Considerations
  2577. VASCULAR COMPLICATIONS
  2578. LIVER TRANSPLANTATION
  2579. Hepatic Artery Thrombosis
  2580. Portal Vein Complications
  2581. Hepatic Vein Obstruction
  2582. Cardiac Vascular Complications
  2583. SURGICAL COMPLICATIONS
  2584. IMMUNOSUPPRESSANT MEDICATION–RELATED COMPLICATIONS
  2585. OTHER EMERGENCIES
  2586. BILIARY COMPLICATIONS
  2587. RECURRENCE OF PRIMARY DISEASE
  2588. ACKNOWLEDGMENT
  2589. SECTION VII: Behavioral Health Emergencies
  2590. CHAPTER 126: BEHAVIORAL AND PSYCHIATRIC EMERGENCIES
  2591. INTRODUCTION
  2592. GOALS OF EMERGENCY MENTAL HEALTH ASSESSMENT AND CRISIS INTERVENTION
  2593. REQUIREMENTS OF THE EMERGENCY DEPARTMENT
  2594. EVALUATION
  2595. Medical History and Physical Examination
  2596. Mental Status of the Child
  2597. Family Evaluation
  2598. Using Social Support
  2599. Resources for ED Clinicians
  2600. GOALS OF TREATMENT FOR AGITATED OR VIOLENT BEHAVIOR
  2601. Clinical Considerations
  2602. SUICIDE ATTEMPTS
  2603. Goals of Emergency Evaluation and Treatment
  2604. Clinical Considerations
  2605. Clinical Recognition
  2606. DEPRESSION
  2607. Goals of Treatment
  2608. Clinical Considerations
  2609. MANIA/BIPOLAR DISORDER
  2610. Goals of Emergency Treatment
  2611. Initial Assessment
  2612. Management
  2613. PSYCHOSIS
  2614. Goals of Emergency Treatment
  2615. Clinical Considerations
  2616. SOMATIC SYMPTOM AND RELATED DISORDERS
  2617. Goals of Treatment
  2618. Clinical Considerations
  2619. Initial Assessment
  2620. Management
  2621. POSTTRAUMATIC STRESS DISORDERS
  2622. PANIC ATTACKS
  2623. CARING FOR CHILDREN WITH AUTISM SPECTRUM DISORDERS IN THE EMERGENCY DEPARTMENT
  2624. Clinical Considerations
  2625. Management
  2626. Challenges in Healthcare Environment
  2627. SCREENING FOR MENTAL HEALTH PROBLEMS IN THE EMERGENCY DEPARTMENT
  2628. CHAPTER 127: SEXUAL ASSAULT: CHILD AND ADOLESCENT
  2629. GOALS OF EMERGENCY CARE
  2630. OVERVIEW OF APPROACH
  2631. Team Composition
  2632. Training
  2633. Assessing and Maintaining Competency
  2634. Assessing and Maintaining Quality
  2635. CURRENT EVIDENCE
  2636. CLINICAL CONSIDERATIONS
  2637. Clinical Recognition
  2638. Triage
  2639. Initial Assessment
  2640. Management/Diagnostic Testing
  2641. Clinical Indications for Discharge or Admission
  2642. NONACUTE SEXUAL ABUSE
  2643. SECTION VIII: Procedures and Appendices
  2644. CHAPTER 128: EQUIPMENT
  2645. EMERGENCY DEPARTMENT
  2646. OFFICE OR CLINIC
  2647. CHAPTER 129: PROCEDURAL SEDATION
  2648. INTRODUCTION
  2649. BACKGROUND
  2650. Barriers to Treatment of Pain in Children
  2651. Impact of Pain and Importance of Successful Pain Management
  2652. Assessment of Pain in Children
  2653. PROCEDURAL SEDATION AND ANALGESIA
  2654. Definitions
  2655. Decision to Perform PSA
  2656. Evaluation and Preparation of Patient Prior to Sedation
  2657. Sedation Protocols
  2658. Choice of Technique and Medications
  2659. METHODS OF DELIVERY
  2660. SEDATIVES
  2661. Benzodiazepines
  2662. Chloral Hydrate
  2663. Barbiturates
  2664. Etomidate
  2665. Propofol
  2666. Nitrous Oxide (N2O)
  2667. Ketamine
  2668. Dexmedetomidine
  2669. ANALGESICS
  2670. Sucrose
  2671. Opioids
  2672. Local Agents
  2673. Specific Uses of Local Agents
  2674. NONPHARMACOLOGIC METHODS FOR PAIN CONTROL
  2675. SPECIAL SITUATIONS
  2676. The Emotionally Labile Child
  2677. COMPLICATIONS AND ERRORS
  2678. Medication Errors
  2679. Documentation
  2680. DISCHARGE MEDICATIONS
  2681. Acetaminophen
  2682. NSAIDs
  2683. Opioids
  2684. SUMMARY
  2685. CHAPTER 130: PROCEDURES
  2686. PREPARATION AND ASSESSMENT OF THE CHILD
  2687. POSITIONING AND RESTRAINTS
  2688. Indications
  2689. Complications
  2690. Procedure
  2691. Positional Support by Caregiver
  2692. Restraint by Personnel
  2693. EXTERNAL JUGULAR VENIPUNCTURE OR PERIPHERAL CANNULATION
  2694. Indications
  2695. Complications
  2696. Equipment
  2697. Procedure
  2698. RADIAL ARTERY PUNCTURE OR CANNULATION
  2699. Indications
  2700. Complications
  2701. Caution
  2702. Equipment
  2703. Procedure
  2704. FEMORAL ARTERY/VEIN PUNCTURE
  2705. Indications
  2706. Contraindications
  2707. Complications
  2708. Equipment
  2709. Procedure
  2710. PERCUTANEOUS FEMORAL VEIN CATHETERIZATION
  2711. Indications
  2712. Complications
  2713. Equipment
  2714. Procedure
  2715. PERCUTANEOUS INTERNAL JUGULAR VEIN CATHETERIZATION
  2716. Indications
  2717. Complications
  2718. Equipment
  2719. Procedure
  2720. SCALP VEIN CATHETERIZATION
  2721. Indications
  2722. Complications
  2723. Equipment
  2724. Procedure
  2725. UMBILICAL ARTERY CATHETERIZATION
  2726. Indications
  2727. Complications
  2728. Equipment
  2729. Procedure
  2730. UMBILICAL VEIN CATHETERIZATION
  2731. Indications
  2732. Complications
  2733. INTRAOSSEOUS INFUSION
  2734. Indications
  2735. Complications
  2736. Equipment
  2737. Procedure
  2738. ACCESSING CENTRAL VENOUS CATHETERS
  2739. Types
  2740. Indications
  2741. Complications
  2742. Equipment
  2743. Procedure
  2744. LUMBAR PUNCTURE
  2745. Indications
  2746. Complications
  2747. Equipment
  2748. Procedure
  2749. PNEUMATIC OTOSCOPIC EXAMINATION
  2750. Indications
  2751. Complications
  2752. Procedure
  2753. REMOVAL OF A FOREIGN BODY FROM THE EAR
  2754. Indications
  2755. Complications
  2756. Procedure
  2757. ASPIRATION OF AN AURICULAR HEMATOMA
  2758. Indications
  2759. Complications
  2760. Procedure
  2761. EVERSION OF THE EYELIDS
  2762. Indications
  2763. Complications
  2764. Procedure
  2765. IRRIGATION OF THE CONJUNCTIVA
  2766. Indications
  2767. Complications
  2768. Procedure
  2769. EYELID RETRACTION
  2770. Indications
  2771. Complications
  2772. Procedure
  2773. CONTACT LENS REMOVAL
  2774. Indications
  2775. Complications
  2776. Procedure
  2777. Soft Contact Lens
  2778. NASAL CAUTERIZATION
  2779. Indications
  2780. Contraindications
  2781. Complications
  2782. Procedure
  2783. NASAL PACKING—ANTERIOR AND POSTERIOR
  2784. Indications
  2785. Complications
  2786. Procedure
  2787. REMOVAL OF A NASAL FOREIGN BODY
  2788. Indications
  2789. Complications
  2790. Procedure
  2791. REIMPLANTATION OF AN AVULSED PERMANENT TOOTH
  2792. Indications
  2793. Contraindications
  2794. Complications
  2795. Equipment
  2796. Procedure
  2797. REPLACEMENT OF A TRACHEOSTOMY CANNULA
  2798. Indications
  2799. Complications
  2800. Procedure
  2801. NEEDLE THORACOSTOMY
  2802. Indications
  2803. Complications
  2804. Equipment
  2805. Procedure
  2806. INSERTION OF A CHEST TUBE
  2807. Indications
  2808. Complications
  2809. Equipment
  2810. Procedure
  2811. INSERTION OF A THORACOSTOMY CATHETER—SELDINGER TECHNIQUE
  2812. Indications
  2813. Complications
  2814. Equipment
  2815. Procedure
  2816. PERICARDIOCENTESIS
  2817. Indications
  2818. Complications
  2819. Equipment
  2820. Procedure
  2821. NASOGASTRIC TUBE PLACEMENT
  2822. Indications
  2823. Complications
  2824. Procedure
  2825. REPLACEMENT OF A GASTROSTOMY TUBE
  2826. Indications
  2827. Contraindications
  2828. Complications
  2829. Equipment
  2830. Procedure
  2831. REDUCTION OF AN INCARCERATED INGUINAL HERNIA
  2832. Indications
  2833. Complications
  2834. Procedure
  2835. RECTAL PROLAPSE
  2836. Indications
  2837. Complications
  2838. Procedure
  2839. CATHETERIZATION OF THE BLADDER
  2840. Indications
  2841. Contraindications
  2842. Complications
  2843. Procedure
  2844. SUPRAPUBIC BLADDER ASPIRATION
  2845. Indications
  2846. Complications
  2847. Procedure
  2848. INCISION AND DRAINAGE OF AN ABSCESS
  2849. Indications
  2850. Complications
  2851. Contraindications
  2852. Procedure
  2853. CLOSED REDUCTION OF DISLOCATIONS
  2854. Finger/Toe Joint Dislocation
  2855. Procedure
  2856. Shoulder (Glenohumeral) Joint Dislocation
  2857. Patella Dislocation
  2858. Elbow Joint Dislocation
  2859. DRAINAGE OF A SUBUNGUAL HEMATOMA
  2860. Indications
  2861. Complications
  2862. Procedure
  2863. INCISION AND DRAINAGE OF A FELON
  2864. Indications
  2865. Complications
  2866. Procedure
  2867. INCISION AND DRAINAGE OF A PARONYCHIA
  2868. Indications
  2869. Complications
  2870. Procedure
  2871. INGROWN TOENAIL REPAIR
  2872. Indications
  2873. Complications
  2874. Procedure
  2875. REMOVAL OF A SUBUNGUAL SPLINTER OR FOREIGN BODY
  2876. Indications
  2877. Complications
  2878. Procedure
  2879. REMOVAL OF RINGS
  2880. Indications
  2881. Complications
  2882. Procedure
  2883. REMOVAL OF A BODY PIERCING
  2884. Indications
  2885. Complications
  2886. Procedure
  2887. REMOVAL OF FISH HOOKS
  2888. Indications
  2889. Complications
  2890. Equipment
  2891. Procedure
  2892. HAIR TOURNIQUET REMOVAL
  2893. Indications
  2894. Complications
  2895. Equipment
  2896. Procedure
  2897. ARTHROCENTESIS—GENERAL CONSIDERATIONS
  2898. Indications
  2899. Complications
  2900. Contraindications (Relative)
  2901. Equipment
  2902. Knee Joint
  2903. TOPICAL ANESTHESIA AND DIRECT WOUND INFILTRATION
  2904. Indications
  2905. Complications
  2906. Equipment
  2907. Procedure
  2908. FIELD BLOCK
  2909. Indications
  2910. Complications
  2911. Equipment
  2912. Procedure
  2913. PERIPHERAL NERVE BLOCKS
  2914. Complications
  2915. Equipment
  2916. Digital and Metacarpal Nerve Block
  2917. Supraorbital Nerve Block
  2918. Infraorbital Nerve Block (Intraoral Approach)
  2919. Mental (Infraoral) Nerve Block
  2920. SPLINTING OF MUSCULOSKELETAL INJURIES
  2921. General Splinting
  2922. Other Issues
  2923. Long Arm Posterior Splint
  2924. Posterior Splint—Below the Knee
  2925. Ankle Stirrup (Sugar Tong) Splint
  2926. Long Leg Posterior Splint
  2927. Ulnar Gutter Splint
  2928. Radial Gutter Splint
  2929. Sugar Tong Splint—Forearm
  2930. Thumb Spica Splint
  2931. Dorsal Extension Finger Splint
  2932. REDUCTION OF NURSEMAID’S ELBOW
  2933. Indications
  2934. Complications
  2935. Procedure
  2936. ACKNOWLEDGMENTS
  2937. CHAPTER 131: ULTRASOUND
  2938. INTRODUCTION
  2939. ADMINISTRATIVE ASPECTS
  2940. Starting a Point-of-Care Ultrasound Program
  2941. Equipment Considerations
  2942. ULTRASOUND BASICS
  2943. Ultrasound Physics
  2944. Basic Controls
  2945. General Scanning Techniques
  2946. DIAGNOSTIC APPLICATIONS
  2947. Focused Assessment With Sonography in Trauma
  2948. Cardiac
  2949. Chest
  2950. Hip
  2951. GENITOURINARY ULTRASOUND
  2952. First Trimester Ultrasound
  2953. Kidney Ultrasound
  2954. Bladder Ultrasound
  2955. Pediatric Abdomen
  2956. Hypertrophic Pyloric Stenosis
  2957. Intussusception
  2958. Appendicitis
  2959. PROCEDURAL APPLICATIONS
  2960. CENTRAL AND PERIPHERAL VENOUS CANNULATION
  2961. Central Venous Cannulation
  2962. Peripheral Venous Cannulation
  2963. Thoracentesis
  2964. Bladder Catheterization
  2965. Lumbar Puncture Guidance
  2966. SOFT TISSUE ULTRASOUND
  2967. Soft Tissue Infections
  2968. Foreign-Body Identification and Removal
  2969. OTHER USES OF ULTRASOUND
  2970. PARACENTESIS AND PERICARDIOCENTESIS
  2971. EVALUATION OF JOINTS
  2972. NERVE BLOCKS
  2973. CHAPTER 132: BIOLOGICAL AND CHEMICAL TERRORISM
  2974. GOALS OF EMERGENCY CARE
  2975. BIOLOGIC AGENTS
  2976. Current Evidence
  2977. GOALS OF TREATMENT
  2978. CLINICAL CONSIDERATIONS
  2979. Clinical Recognition
  2980. Triage Considerations: Minimizing Spread of Infection
  2981. CLINICAL ASSESSMENT AND MANAGEMENT
  2982. Specific Agents
  2983. VIRAL HEMORRHAGIC FEVERS
  2984. Ricin
  2985. OTHER AGENTS
  2986. CHEMICAL AGENTS
  2987. Current Evidence
  2988. Goals of Treatment
  2989. Clinical Considerations
  2990. CLINICAL ASSESSMENT AND MANAGEMENT
  2991. Specific Agents
  2992. Vesicants
  2993. Pulmonary Agents
  2994. Cyanide
  2995. Riot-Control Agents
  2996. Miscellaneous Chemicals
  2997. Emergency Department Preparedness
  2998. CONCLUSION
  2999. CHAPTER 133: INSTRUCTIONS FOR PARENTS
  3000. DISCHARGE INSTRUCTIONS
  3001. LEGAL AND REGULATORY CONSIDERATIONS
  3002. Meaningful Use
  3003. Legal Considerations
  3004. GENERAL PRINCIPLES OF DISCHARGE INSTRUCTIONS
  3005. Organization
  3006. DISCHARGE INSTRUCTION FORMATS
  3007. Verbal Instructions
  3008. Written Instructions
  3009. Multimedia Technology
  3010. Combination Method: The Preferred Method
  3011. OBSTACLES TO COMPREHENSION AND RETENTION OF DISCHARGE INSTRUCTIONS
  3012. LITERACY AND LANGUAGE COMPREHENSION
  3013. NONNATIVE ENGLISH-SPEAKING PATIENTS
  3014. MEDICATIONS AND MEDICATION RECONCILIATION
  3015. FOLLOW-UP
  3016. SUMMARY
  3017. CHAPTER 134: PREHOSPITAL CARE
  3018. EMS SYSTEMS
  3019. History of EMS Systems
  3020. Epidemiology
  3021. Governance of EMS Systems
  3022. Components of Prehospital Care Systems
  3023. EMS Providers
  3024. Medical Oversight of EMS
  3025. EMERGENCY MEDICAL DISPATCHERS AND DISPATCH PRINCIPLES
  3026. EQUIPMENT AND MODES OF TRANSPORT
  3027. COMMUNICATION
  3028. Equipment
  3029. EMS Reports to Hospital Personnel
  3030. Medical Records
  3031. Telemedicine in EMS
  3032. ISSUES IN EMS CARE
  3033. Culture of Safety
  3034. MEDICAL–LEGAL ISSUES
  3035. REGIONALIZATION
  3036. PEDIATRIC PREHOSPITAL AIRWAY MANAGEMENT
  3037. CHILDREN WITH SPECIAL HEALTHCARE NEEDS
  3038. EMERGENCY PREPAREDNESS
  3039. EMS FOR CHILDREN PROGRAM
  3040. History of EMS for Children
  3041. ROLE OF THE PEDIATRICIAN/PEDIATRIC EM PROVIDER IN EMS FOR CHILDREN
  3042. IOM REPORTS
  3043. EMS RESEARCH
  3044. EVIDENCE-BASED GUIDELINES
  3045. SUMMARY
  3046. CHAPTER 135: TECHNOLOGY-ASSISTED CHILDREN
  3047. INTRODUCTION
  3048. APPROACH TO THE CARE OF THE TECHNOLOGY-ASSISTED CHILD
  3049. TRACHEOSTOMY CARE
  3050. Background
  3051. Pathophysiology
  3052. Equipment
  3053. Clinical Findings/Management
  3054. CEREBROSPINAL FLUID SHUNTS
  3055. Background
  3056. Pathophysiology
  3057. Equipment
  3058. Clinical Findings/Management
  3059. INDWELLING VENOUS ACCESS DEVICES
  3060. Background
  3061. Pathophysiology
  3062. Equipment
  3063. Clinical Findings/Management
  3064. ENTERAL FEEDING TUBES
  3065. Background
  3066. Pathophysiology
  3067. Equipment
  3068. Clinical Findings/Management
  3069. GASTROINTESTINAL AND GENITOURINARY DIVERSION
  3070. Background
  3071. Pathophysiology
  3072. Equipment
  3073. Clinical Findings/Management
  3074. Urinary Diversions
  3075. Index

 

 

 


An aparitie 23 Sept. 2020
Autor James Chamberlain , Jane Lavelle , Joshua Nagler MD MHPEd , Joan E. Shook
Dimensiuni 21.84 x 5.08 x 28.19 cm
Editura LWW
Format Hardcover
ISBN 9781975121518
Limba Engleza
Nr pag 1528

Clientii ebookshop.ro nu au adaugat inca opinii pentru acest produs. Fii primul care adauga o parere, folosind formularul de mai jos.

Spune-ne parerea ta despre acest produs

Nota acordata produsului:

Notificare prin e-mail cand apar comentarii noi
Scroll